fibrinogen has been researched along with Hyperlipemia in 192 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 54 (28.13) | 18.7374 |
| 1990's | 60 (31.25) | 18.2507 |
| 2000's | 61 (31.77) | 29.6817 |
| 2010's | 15 (7.81) | 24.3611 |
| 2020's | 2 (1.04) | 2.80 |
| Authors | Studies |
|---|---|
| Antonelli, G; Bernardi, D; Negrini, D; Plebani, M | 1 |
| Cao, P; Chan, L; Chan, P; Chang, Z; Chao, Y; Chen, Z; Deng, B; Lyu, Q; Pan, Y; Que, R; Tan, EK; Wang, Q; Wang, T; Wang, Y; Xu, L; Yang, W; Yenari, MA; Yuan, F; Zhu, S | 1 |
| Bliden, KP; Cho, A; Gurbel, PA; Jerjian, C; Levy, JH; Rapista, N; Tantry, US; Walia, N | 1 |
| Abd El-Aty, AM; Chung, YH; Jeong, JH; Jung, TW; Kim, HC | 1 |
| Chang, SJ; Ham, JH; Kim, DH; Kim, SH; Lee, JY; Lee, SS; Lim, EJ; Park, CI; Song, YK | 1 |
| Cohen, BE; Grenon, SM; Hiramoto, J; Smolderen, K; Vittinghoff, E; Whooley, MA | 1 |
| Baj, Z; Chmielewski, H; Kaczorowska, B; Pawelczyk, M; Przybyła, M | 1 |
| Gao, BL; Su, BY; Tian, CF; Tong, YH; Zhao, XH; Zheng, Y | 1 |
| Fehér, G; Horváth, B; Komoly, S; Márton, Z; Szapáry, L; Tóth, K | 1 |
| Fang, B; Guan, C; Huang, L; Yang, G; Zhu, Y | 1 |
| Corella, D; Martínez Triguero, M; Plumé, G; Ricart, A; Romagnoli, M; Solves, P; Vayá, A | 1 |
| Bai, CH; Chen, WH; Chuang, SY; Lien, LM; Pan, WH | 1 |
| Aktoz, M; Ozcelik, F; Tatli, E | 1 |
| Ak, K; Arsan, S; Eksioglu-Demiralp, E; Iqbal, O; Isbir, S; Tetik, S; Yardimci, T | 1 |
| Chen, J; Cong, H; Du, L; Fang, B; Yin, L; You, C; Zhao, H | 1 |
| Bicanic, G; Kekic, B; Oreskovic, Z; Shejbal, D | 1 |
| Ding, Y; Ji, X; Li, ZY; Meng, R; Meng, S; Wang, X | 1 |
| Bălşeanu, AT; Dănoiu, S; Iancu, I; Mitran, SI; Moţa, M; Pisoschi, C; Riza, A; Sfredel, V | 1 |
| Bhadada, SV; Dhamecha, PS; Ghatak, SB; Panchal, SJ | 1 |
| Acevedo-Flores, M; Adubato, S; Allison, K; Baig, M; Barr, E; Belanger, R; Bettica, L; Borkowsky, W; Borne, C; Burchett, S; Burey, M; Cagwin, E; Chambers, C; Chen, J; Cintron, A; Cooper, N; Dieudonne, A; DiMeglio, LA; Dooley, L; Garvie, P; Geffner, ME; Gobs, E; Grant, M; Harris, L; Hazra, R; Himic, L; Hunter, S; Jacobson, DL; Kammerer, B; Karthas, N; Knapp, K; Malee, K; McFarland, E; McFarland, EJ; Mendez, AJ; Messenger, N; Miller, TI; Navarro, S; Nichols, S; Norris, K; Nozyce, M; Olivera, V; Patel, K; Patton, D; Puga, A; Purswani, M; Rios, H; Scott, G; Shearer, W; Siberry, GK; Silio, M; Sirois, P; Spector, S; Van Dyke, RB; Watson, D; Willen, E; Wiznia, A; Worrell, CJ; Yogev, R | 1 |
| Baena-Díez, JM; Félix-Redondo, FJ; Fernández-Bergés, D; Grau, M; Tormo, MÁ | 1 |
| Chambon, C; Dejeans, N; Herosimczyk, A; Maier, JA; Martin, JF; Mazur, A; Sayd, T; Tauveron, I | 1 |
| Asakura, H; Ishino, C; Kanno, M; Matsuda, T; Minami, S; Morishita, E; Nakao, S; Uotani, C | 1 |
| Andersen, RE; Crespo, CJ; Sempos, CT; Smit, E; Snelling, A | 1 |
| Dabrowski, M; Gajewski, M; Karpiński, M; Kosior, J; Kubik, L; Pecak, R; Płocharski, A; Skolimowska, B; Stankiewicz, W; Szmigielski, S | 1 |
| Biondi, B; Fazio, S; Lombardi, G; Nuzzo, V; Palmieri, EA; Pulcrano, M; Rossi, R; Tauchmanovà, L | 1 |
| Avcu, F; Ural, AU; Yalcin, A; Yilmaz, MI | 1 |
| Bairaktari, E; Elisaf, M; Ganotakis, E; Mikhailidis, DP; Rizos, E; Tsimihodimos, V | 1 |
| Efthimiou, Y; Kritz, H; Sinzinger, H; Stomatopoulos, J; Wolfram, RM | 1 |
| Ebano, V; Fruscella, M; Imperato, F; Marziani, R; Mossa, B; Perniola, G | 1 |
| Albertini, F; Ascari, L; Assanelli, D; Boldini, A; Brentana, L; Di Castelnuovo, A; Ferrari, R; Galeazzi, GL; Iacoviello, L; Maccalli, P | 1 |
| Catalano, F; Cutrupi, S; Funahashi, T; Kihara, S; Mallamaci, F; Matsuzawa, Y; Ouchi, N; Panuccio, V; Parlongo, S; Tanaka, S; Tripepi, G; Zoccali, C | 1 |
| Ahn, JY; Ahn, TH; Choi, IS; Han, SH; Kim, DS; Koh, KK; Park, GS; Shin, EK; Son, JW | 1 |
| Alexy, T; Gaál, V; Horváth, B; Juricskay, I; Késmárky, G; Koltai, K; Márton, Z; Nagy, F; Pálfi, A; Szapáry, L; Szóts, M; Tóth, K | 1 |
| Chew, EY | 1 |
| De Maat, MP; Huisman, MV; Kluft, C; Meinders, AE; Princen, HM; Van De Ree, MA | 1 |
| STAFFORD, JL | 1 |
| Cui, CC; Wang, JK; Yao, QH | 1 |
| Berger, D; Demarmels Biasiutti, F; Lämmle, B; Mattle, HP; Wuillemin, WA | 1 |
| Alexy, T; Czopf, J; Demeter, N; Gaal, V; Horvath, B; Juricskay, I; Kesmarky, G; Klabuzai, A; Marton, Z; Szapary, L; Szots, M; Toth, K | 1 |
| Bartnik, M; Efendic, S; Hamsten, A; Malmberg, K; Norhammar, A; Ohrvik, J; Rydén, L; Silveira, A; Tenerz, A | 1 |
| Dobordzhginidze, LM | 1 |
| Brennan, SO; George, PM; Maghzal, GJ | 1 |
| Bairaktari, ET; Elisaf, MS; Goudevenos, J; Liberopoulos, E; Milionis, HJ; Seferiadis, K | 1 |
| Ansquer, JC; Foucher, C; Rattier, S; Steiner, G; Taskinen, MR | 1 |
| Alacacioglu, A; Caliskan, S; Ceylan, C; Comlekci, A; Saklamaz, A; Temiz, A; Yesil, S | 1 |
| Kobus, G; Małyszko, J; Myśyliwiec, M | 1 |
| Aso, Y; Inukai, T; Inukai, Y; Matsumoto, S; Matsutomo, R; Takebayashi, K; Wakabayashi, S | 1 |
| Ciechanowicz, A; Foltyńska-Nowakowska, A; Goracy, I; Jastrzebska, M; Naruszewicz, M; Torbus-Lisiecka, B; Wesołowska, T; Widecka, K | 1 |
| Amagasa, H; Iwai, S; Kobayashi, S; Kumai, T; Oguchi, K; Okazaki, M | 1 |
| Chang, GT; Kim, CH; Kim, JH; Kim, JK; Kim, SH; Min, SY | 1 |
| Demirel, GY; Oba, R; Ozsavci, D; Sener, A; Uras, F; Yardimci, KT | 1 |
| Einecke, D | 1 |
| Carey, HM; Carter, TR; Elliott, MJ; Kull, AD; Morel-Kopp, MC; Philcox, S; Schenck, K; Taylor, BA; Tofler, GH; Ward, C | 1 |
| Arocha-Piñango, CL; Carvajal, Z; Castillo, L; Espinosa, RA; Gil, A; Lundberg, U; Mijares, ME; Nagy, E; Rodríguez-Larralde, A; Rodríguez-Roa, E | 1 |
| Antonova, N; Dimitrov, N; Dimitrova, V; Ivanov, I; Velcheva, I | 1 |
| Balakhonova, TV; Kukharchuk, VV; Masenko, VP; Pogorelova, OA; Susekov, AV; Tripoten', MI; Zubareva, Mi | 1 |
| Gomibuchi, H; Iwai, S; Kobayashi, S; Kumai, T; Oguchi, K; Okazaki, M | 1 |
| Ezhov, MV; Kukharchuk, VV; Naumov, VG; Samoĭlenko, EIu; Sergienko, IV; Tvorogova, MG | 1 |
| Chou, CW; Hsiao, SH; Kao, PC; Lin, CY; Ou, HY; Wu, TJ | 1 |
| Corella, D; España, F; Falcó, C; Ferrando, F; Mira, Y; Simó, M; Todolí, J; Vayá, A | 1 |
| Chae, JS; Choi, D; Heo, YM; Huttner, K; Hyun, YJ; Jang, Y; Kim, OY; Koh, SJ; Lee, JH; Shin, DJ | 1 |
| Jarvis, BW | 1 |
| Blombäck, M; Ekelund, LG; Olsson, AG | 1 |
| Cai, BL | 1 |
| Cucuianu, MP; Missits, I; Olinic, N; Roman, S | 1 |
| Zajtchuk, J; Zajtchuk, R | 1 |
| Cristea, A; Cucuianu, MP; Missits, I; Roman, S | 1 |
| Arora, RC; Arora, S | 1 |
| Killner, MS; Lees, RS | 1 |
| He, G; Lu, R; Shen, X | 1 |
| Argimón, JM; Castells, A; Domenech, P; Espínola, A; Fiol, C; Pintó, X; Val, A | 1 |
| Krüger, B | 1 |
| Koschyk, DH; Langes, K; Nienaber, CA; Rinninger, F; Schneider, MA; Volk, C | 1 |
| Miller, GJ | 1 |
| Feely, J; Holden, RD; Johnston, GD; Radley, DR; Vyssoulis, G | 1 |
| Lip, GY | 1 |
| Binaghi, F; Cannas, F; Caredda, E; Fronteddu, PF; Garau, P; Pitzus, F; Uras, A | 1 |
| Ichino, K; Nakayama, S; Oguchi, K; Okazaki, M; Yoshida, Y; Zhang, H | 1 |
| Angós, JA; Cornudella, R; Gálvez, MM; Gutiérrez, M; Moreno, JA; Romero, MS | 1 |
| Barbir, M; Galloway, D; Hunt, BJ; Ilsley, C; Mitchell, A; Taylor, A; Yacoub, M | 1 |
| Glueck, CJ; Glueck, HI; Speirs, J; Stroop, D; Tracy, T | 1 |
| Gustafsson, IB; Nydahl, MC; Vessby, B | 1 |
| Bosch, T; Gurland, HJ; Samtleben, W; Seidel, D; Thiery, J | 1 |
| Ramires, JA; Serrano Júnior, CV | 1 |
| Asada, R; Kario, K; Kobayashi, H; Matsuo, M; Matsuo, T | 1 |
| Anagnostou, ED; Chatzidimitriou, GI; Megalou, AA; Papageorgakis, NH; Rallidis, LS; Tsitouris, GK | 1 |
| de Valois, JC; Kastelein, JJ; Knipscheer, HC; van den Ende, B; Wouter ten Cate, J | 1 |
| Angelin, B; Bröijersén, A; Eriksson, M; Fatah, K; Goodall, AH; Hamsten, A; Hjemdahl, P; Silveira, A | 1 |
| Bai, CH; Chen, JR; Chiu, HC; Pan, WH | 1 |
| de Maat, MP; Kastelein, JJ; Kluft, C; Knipscheer, HC | 1 |
| Barradell, LB; Goa, KL; Plosker, GL | 1 |
| Fujishlma, M; Iwase, M; Takano, K; Waklsaka, M; Yamamoto, M; Yoshinari, M | 1 |
| Jeck, T; Keller, U; Riesen, WF | 1 |
| Wray, R | 1 |
| Boberg, M; Kilander, L; Lithell, H; Nyman, H | 1 |
| Boda, Z | 1 |
| Castro, P; Concha, M; Jimenéz-Perepérez, JA; López-Miranda, J; Montilla, P; Pérez-Jiménez, F; Vallés, F; Velasco, F; Zambrana, JL | 1 |
| Chen, Y; Wang, C; Zhao, L | 1 |
| Asanuma, H; Funaya, H; Hori, M; Kitakaze, M; Koretsune, Y; Minamino, T; Sato, H | 1 |
| Jäger, K; Labs, KH; Marbet, GA; Tsakiris, DA; Tschopl, M | 1 |
| Altman, R | 1 |
| Artigao, LM; Divisón, JA; García Gosálvez, F; López Abril, J; Naharro, F; Puras, A; Rodríguez Paños, B; Sanchís, C | 1 |
| Burger, HM; Jerling, JC; Oosthuizen, W; Smuts, CM; Veldman, FJ; Vermaak, WJ; Vorster, HH | 1 |
| Wanner, C; Zimmermann, J | 1 |
| Basili, S; Iuliano, L; Longoni, A; Milani, M; Vieri, M; Violi, F | 1 |
| Sussekov, AV | 1 |
| Aillaud, MF; Amouyel, P; Arveiler, D; Evans, A; Ferrières, J; Juhan-Vague, I; Luc, G; Scarabin, PY | 1 |
| Bellotti, G; Gebara, OC; Lipinska, I; Mittleman, MA; Muller, JE; Sacks, FK; Tofler, GH; Walsh, BW; Welty, FK | 1 |
| Belichard, P; Bontemps, L; de Lorgeril, M; Geyssant, A; Itti, R; Salen, P | 1 |
| Byrne, DJ; Ganotakis, ES; Jagroop, IA; Mikhailidis, DP; Spyropoulos, KA; Winder, AF | 1 |
| Berglund, L; Diczfalusy, U; Heimbürger, O; Jogestrand, T; Paultre, F; Stenvinkel, P; Wang, T | 1 |
| Titus, K | 1 |
| Bairaktari, ET; Elisaf, MS; Liberopoulos, EN; Miltiadous, GA; Tsimihodimos, VK; Tzallas, CS | 1 |
| Ganotakis, ES; Jagroop, IA; Mikhailidis, DP; Papadakis, JA; Winder, AF | 1 |
| Chelstowski, K; Jastrzebska, M; Kopciewicz, J; Naruszewicz, M; Pieczul-Mróz, J; Torbus-Lisiecka, B | 1 |
| Hamann, GF; Jaeger, BR; Knüppel, HP; Pfefferkorn, TK; Thiery, J | 1 |
| Rodrigues, M; Sinzinger, H | 1 |
| Aznar, J; Gabriel, F; Guiral, V; Labios, M; Martínez, M; Vayá, A | 1 |
| Bruckert, E; Chadarevian, R; Giral, P; Turpin, G | 1 |
| Dominiczak, MH | 2 |
| Bønaa, KH; Hansen, JB; Nilsen, H; Nordøy, A; Sandset, PM | 1 |
| Jerling, JC; Oosthuizen, W; Scholtz, CS; Vermaak, WJ; Vorster, HH | 1 |
| Dagianti, A; Penco, M; Romano, S; Tozzi-Ciancarelli, MG | 1 |
| Bengtsson, BA | 1 |
| Alfón, J; Badimon, L; Berrozpe, M; Royo, T | 1 |
| Bairaktari, E; Elisaf, MS; Kiortisis, DN; Millionis, H | 1 |
| Hense, HW; Tuut, M | 1 |
| Hirano, T; Kazumi, T; Yoshino, G | 1 |
| Aguilar-Salinas, CA; Fanghänel-Salmón, G; Gómez Pérez, FJ; González-Valdez, H; Gulías-Herrero, A; Meza, E; Monterrubio-Flores, EA; Montes, J; Sánchez, L | 1 |
| Cibulová, L; Dzúrik, R; Gajdos, M; Huttová, D; Krivosíková, Z; Mongiellová, V; Spustová, V | 1 |
| Nilova, TV; Zvenigorodskaia, LA | 1 |
| Goodson, N | 1 |
| Arber, N; Avitzour, D; Berliner, S; Elishkewich, K; Fusman, R; Izkhacov, E; Rotstein, R; Rubinstein, A; Shapira, I; Zeltser, D | 1 |
| Achimastos, A; Bairaktari, E; Elisaf, M; Liberopoulos, E; Miltiadous, G; Nikas, S; Tsimihodimos, V | 1 |
| Athyros, VG; Athyrou, VV; Demitriadis, DS; Kontopoulos, AG; Papageorgiou, AA | 1 |
| Aznar, J; Contreras, M; Corella, D; España, F; Estelles, A; Ferrando, F; Mira, Y; Vayá, A | 1 |
| Leonhardt, H; Uthoff, A; Uthoff, C | 1 |
| Bakowski, M; Betteridge, DJ; de Silva, SR; Galton, DJ; Reckless, JP; Taylor, KG | 1 |
| Stone, MC; Thorp, JM; Wain, JS | 1 |
| Gross, W; Zöller, H | 1 |
| Cabral, RB; Carvalho, AC; Colman, RW; Lees, RS; Vaillancourt, RA; Weinberg, RM | 1 |
| Lundsgaard-Hansen, P | 1 |
| Dudaev, VA; Evdokimov, VV | 1 |
| Boberg, J; Hedstrand, H; Hellsing, K; Lithell, H; Ljunghall, S; Vessby, B | 1 |
| Zöller, H | 1 |
| Dell, RB; Goodman, DS; Merskey, C; Nossel, HL; Sciacca, RR; Seplowitz, AH; Smith, FR | 1 |
| Govseeva, NN; Kondrat'eva, LG; Solovtsova, KM; Vendt, VP | 1 |
| Nossel, HL | 1 |
| Boberg, J; Hellsing, K; Lithell, H; Vessby, B; Werner, I | 1 |
| Berman, IR; Lackner, H; Ranson, JH; Schinella, R | 1 |
| Andrassy, K; Barth, P; Ehlers, W; Hoffrichter, A; Lang, PD; Schlierf, G; Walter, E; Weber, E; Zimmermann, R | 1 |
| Belousov, IuB; Dudaev, VA; Liusov, VA; Shmushkovich, BI | 1 |
| Andersen, P | 1 |
| Duarte, AM; Escribano, CG; Lucio, FJ; Marques, LD; Puyol, MR | 1 |
| Abbey, M; Belling, GB; Clifton, PM; Cobiac, L; Nestel, PJ | 1 |
| Hultin, MB | 1 |
| Kleophas, W; Leschke, M; Reinauer, H; Saddig, C; Strauer, BE; Toeller, M | 1 |
| Carey, H; Feher, MD; Knapp, ML; Mayne, PD | 1 |
| Kannel, WB | 2 |
| Calabrò, A; Ciuffetti, G; Crepaldi, G; Descovich, GC; Fellin, R; Gaddi, A; Mannarino, E; Rossi, A; Senin, U; Ventura, A | 1 |
| Oguchi, K; Okazaki, M; Suzuki, M | 1 |
| Ciuffetti, G; Lombardini, R; Lupattelli, G; Mannarino, E; Mercuri, M; Pasqualini, L; Susta, A | 1 |
| Aĭngorn, ED; Andreenko, GV; Belokon', NA; Karabasova, MA; Zabotina, ON | 1 |
| Schafer, AI | 1 |
| Fuse, Y | 1 |
| Conoscenti, E; Dolfi, R; Fabbiani, N; Falco, F; Gloria, R; Moronesi, F; Pepe, R; Pisano, L; Stipa, E | 1 |
| Jacobs, P; Wood, L | 1 |
| Banga, JD; Sixma, JJ | 1 |
| Fazekas, F; Lechner, H; Ott, E; Valetitsch, H | 1 |
| Fenwick, GR; Hanley, AB | 1 |
| Bansal, HC; Bordia, A | 1 |
| Brakman, P; Epstein, SE; Redwood, DR; Rosing, DR | 1 |
| Astrup, T; Brakman, P; Fredrickson, DS; Levy, RI | 1 |
| Bellet, M; Lange, D; Le Lourd, F; Le Lourd, R; Reboul, J | 1 |
| Anet, P; Brouns, H; Delescluse, A; van den Abelle, KG | 1 |
| Astrup, T; Brakman, P; Epstein, SE; Redwood, DR; Rosing, DR | 1 |
| Wardle, EN | 1 |
| Glueck, CJ; Glueck, HI | 1 |
| Cucuianu, M; Popescu, TA; Vasile, V | 1 |
| Cucuianu, M; Hărăguş, S; Opincaru, A; Uza, G | 1 |
| Mantovani, M; Prino, G | 1 |
| Braunsteiner, H; Holzknecht, F; Spöttl, F | 1 |
| Fukuzaki, H; Imamura, H; Ishihama, Y; Matsuo, T; Yoshida, M | 1 |
| Takamiya, T | 1 |
| Beaumont, JL; Buxtorf, JC; Gorin, N; Jacotot, B | 1 |
| Krivoruchenko, IV | 1 |
| Fitzgerald, JD | 1 |
| Burckhardt, D; LaDue, JS; Vera, CA | 1 |
| Foldenauer, A; Suschke, J | 1 |
21 review(s) available for fibrinogen and Hyperlipemia
| Article | Year |
|---|---|
Epidemiology of diabetic retinopathy.
Topics: Anemia; Diabetic Retinopathy; Disease Progression; Fibrinogen; Humans; Hyperglycemia; Hyperlipidemias; Hypertension; Risk Factors; Serum Albumin | 2003 |
THE FIBRINOLYTIC MECHANISM IN HAEMOSTASIS: A REVIEW.
Topics: Blood Platelets; Fibrin; Fibrinogen; Fibrinolysis; Hemostasis; Humans; Hyperlipidemias; Lipid Metabolism; Lipoproteins; Plasminogen; Thrombosis | 1964 |
[Fibrates: mechanism of action, effect on levels of lipids and risk of coronary events. II. Fenofibrate].
Topics: Adult; Aged; Cholesterol; Coronary Disease; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Fenofibrate; Fibrinogen; Homocysteine; Humans; Hyperlipidemias; Hypolipidemic Agents; Insulin Resistance; Lipids; Male; Middle Aged; Placebos; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Factors; Triglycerides | 2004 |
Lipoproteins and thrombosis: effects of lipid lowering.
Topics: Blood Coagulation; Blood Platelets; Coronary Thrombosis; Fibrinogen; Fibrinolysis; Humans; Hyperlipidemias; Lipoproteins | 1995 |
Fibrinogen and cardiovascular disorders.
Topics: Biomarkers; Cardiovascular Diseases; Cerebrovascular Disorders; Female; Fibrinogen; Gonadal Steroid Hormones; Heart Diseases; Humans; Hyperlipidemias; Hypertension; Male; Risk Factors; Smoking | 1995 |
[Dyslipidemia and blood coagulation].
Topics: Arteriosclerosis; Blood Coagulation; Blood Platelets; Coronary Thrombosis; Factor VII; Fibrinogen; Humans; Hypercholesterolemia; Hyperlipidemias; Lipoproteins; Risk Factors | 1995 |
Bezafibrate. An update of its pharmacology and use in the management of dyslipidaemia.
Topics: Angina Pectoris; Apolipoproteins; Apolipoproteins A; Bezafibrate; Diabetes Complications; Drug Tolerance; Fibrinogen; Glucose; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypolipidemic Agents; Insulin Resistance; Lipoproteins; Male; Myocardial Infarction | 1996 |
[Fibrinogen as an independent cardiovascular risk factor and the question of treatment with fibrinogen-lowering drugs].
Topics: Anticoagulants; Arteriosclerosis; Blood Coagulation Factors; Cholesterol; Female; Fibrinogen; Humans; Hypercholesterolemia; Hyperlipidemias; Hypertension; Lipoproteins; Male; Obesity; Risk Factors; Sex Factors; Smoking | 1997 |
Assessment of effects of lipid-lowering drugs on hemostasis.
Topics: Biomarkers; Blood Viscosity; Fibrinogen; Hemostasis; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipids; Platelet Aggregation; Treatment Outcome | 1998 |
Causes of coronary heart disease in patients on renal replacement therapy.
Topics: Animals; Apolipoproteins B; Coronary Disease; Fibrinogen; Homocysteine; Humans; Hyperlipidemias; Kidney Failure, Chronic; Lipoprotein(a); Renal Dialysis; Risk Factors | 1998 |
A panorama of cardiac risk.
Topics: Adult; Aged; Amyloid; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cerebrovascular Disorders; Cholesterol; Cholesterol, LDL; Clinical Trials as Topic; Female; Fibrinogen; Follow-Up Studies; Homocysteine; Humans; Hyperlipidemias; Lipoprotein(a); Male; Middle Aged; Myocardial Infarction; Prospective Studies; Research; Retrospective Studies; Risk Factors; Time Factors; Triglycerides; Vitamin E | 1999 |
Hyperlipidaemia and cardiovascular disease.
Topics: Adolescent; Adult; Cardiovascular Diseases; Female; Fibrinogen; Humans; Hyperlipidemias; Male; Obesity; Risk Factors | 2000 |
[BECAIT [Bezafibrate Coronary Atherosclerosis Intervention Trial]].
Topics: Bezafibrate; Cholesterol, HDL; Coronary Artery Disease; Fibrinogen; Follow-Up Studies; Humans; Hyperlipidemias; Hypolipidemic Agents; Male; Middle Aged; Myocardial Infarction; Randomized Controlled Trials as Topic; Triglycerides | 2001 |
Coronary artery disease and rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; C-Reactive Protein; Comorbidity; Coronary Artery Disease; Fibrinogen; Homocysteine; Humans; Hyperlipidemias; Hypertension; Risk Factors; Smoking; Survival Analysis; Survival Rate | 2002 |
[Coagulation and fibrinolytic system in the vascular risks diabetes mellitus and hyperlipoproteinemia (author's transl)].
Topics: Adult; Aged; Antithrombins; Blood Coagulation; Cholesterol; Diabetes Mellitus; Diabetic Angiopathies; Female; Fibrinogen; Fibrinolysis; Humans; Hyperlipidemias; Male; Middle Aged; Platelet Aggregation; Risk; Thrombocytopenia; Triglycerides | 1978 |
Hypercoagulability and reduced fibrinolysis in hyperlipidemia: relationship to the metabolic cardiovascular syndrome.
Topics: Blood Coagulation; Cardiovascular Diseases; Cholesterol; Coronary Disease; Fibrinogen; Fibrinolysis; Humans; Hyperlipidemias; Lipoproteins, LDL; Metabolic Diseases; Plasminogen Inactivators; Syndrome | 1992 |
Fibrinogen and factor VII as risk factors in vascular disease.
Topics: Adult; Aged; Animals; Cardiovascular Diseases; Cerebrovascular Disorders; Cohort Studies; Cross-Sectional Studies; Epidemiologic Methods; Europe; Factor VII; Female; Fibrinogen; Hemostasis; Humans; Hyperlipidemias; Lipoproteins; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Risk Factors; Thromboplastin; Triglycerides; United States | 1991 |
The hypercoagulable states.
Topics: Antithrombin III Deficiency; Arterial Occlusive Diseases; Biocompatible Materials; Blood Coagulation Disorders; Blood Coagulation Factors; Blood Viscosity; Contraceptives, Oral; Diabetes Complications; Factor XII Deficiency; Female; Fibrinogen; Fibrinolysis; Glycoproteins; Hemoglobinuria, Paroxysmal; Homocystinuria; Humans; Hyperlipidemias; Lupus Coagulation Inhibitor; Myeloproliferative Disorders; Neoplasms; Nephrotic Syndrome; Pregnancy; Pregnancy Complications, Hematologic; Protein C; Protein S; Purpura, Thrombotic Thrombocytopenic; Thrombocytopenia; Thrombocytosis; Thromboembolism; Vasculitis; Venous Insufficiency | 1985 |
Diabetes mellitus, vascular disease and thrombosis.
Topics: Blood Coagulation Factors; Blood Platelets; Blood Viscosity; Cholesterol, HDL; Coronary Disease; Diabetic Angiopathies; Erythrocyte Deformability; Fibrinogen; Fibrinolysis; Hemostasis; Humans; Hypercholesterolemia; Hyperlipidemias; Platelet Adhesiveness | 1986 |
The genus Allium--Part 3.
Topics: Allium; Animals; Arteriosclerosis; Asthma; Bacteria; Blood Glucose; Blood Protein Electrophoresis; Cholesterol; Clofibrate; Coronary Disease; Dermatitis, Contact; Dietary Fats; Drug Interactions; Fibrinogen; Fibrinolysis; Fungi; Garlic; Humans; Hyperlipidemias; Insecta; Microbial Sensitivity Tests; Mutagenicity Tests; Neoplasms; Oils, Volatile; Patch Tests; Plant Extracts; Plants, Medicinal; Platelet Aggregation; Prothrombin Time; Rabbits; Whole Blood Coagulation Time | 1985 |
[Hyperlipemia and hypofibrinolysis in arteriosclerotic disease].
Topics: Adult; Animals; Arteriosclerosis; Blood Coagulation Tests; Cholesterol; Coronary Disease; Diet; Diet, Atherogenic; Fats; Fats, Unsaturated; Female; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Humans; Hyperlipidemias; Iodine Isotopes; Lipoproteins; Male; Methods; Middle Aged; Rabbits; Rats; Tissue Extracts | 1967 |
39 trial(s) available for fibrinogen and Hyperlipemia
| Article | Year |
|---|---|
Clopidogrel provides significantly greater inhibition of platelet activity than aspirin when combined with atorvastatin after coronary artery bypass grafting: a prospective randomized study.
Topics: Adenosine Diphosphate; Aged; Aspirin; Atorvastatin; Clopidogrel; Comorbidity; Coronary Artery Bypass; Coronary Disease; Drug Therapy, Combination; Female; Fibrinogen; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Lipoproteins, LDL; Male; Middle Aged; P-Selectin; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Postoperative Complications; Prospective Studies; Pyrroles; Ticlopidine | 2010 |
Atorvastatin reduces plasma levels of factor VII activity and factor VII antigen in patients with hyperlipidemia.
Topics: Aged; Anticholesteremic Agents; Antigens; Atorvastatin; Blood Glucose; Factor VII; Female; Fibrinogen; Hemostasis; Heptanoic Acids; Humans; Hyperlipidemias; Isoantigens; Male; Middle Aged; Pyrroles; Risk Factors; Thrombosis; Triglycerides | 2002 |
Treatment with cerivastatin in primary mixed hyperlipidemia induces changes in platelet aggregation and coagulation system components.
Topics: Administration, Oral; Blood Coagulation; Blood Coagulation Factors; Collagen; Female; Fibrinogen; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Lipids; Male; Middle Aged; Myocardial Ischemia; Platelet Aggregation; Platelet Count; Pyridines; Treatment Outcome | 2002 |
Effect of ciprofibrate on lipoproteins, fibrinogen, renal function, and hepatic enzymes.
Topics: Analysis of Variance; Cholesterol; Clofibric Acid; Female; Fibric Acids; Fibrinogen; Humans; Hyperlipidemias; Kidney; Lipoproteins; Liver; Male; Statistics, Nonparametric; Triglycerides | 2002 |
Decrease of hemostatic cardiovascular risk factors by aggressive vs. conventional atorvastatin treatment in patients with Type 2 diabetes mellitus.
Topics: Aged; Atorvastatin; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Double-Blind Method; Factor VIIIa; Female; Fibrinogen; Hemostatics; Heptanoic Acids; Humans; Hyperlipidemias; Male; Middle Aged; Placebos; Pyrroles; Risk Factors; Time Factors; Tissue Plasminogen Activator; von Willebrand Factor | 2003 |
Fenofibrate reduces progression to microalbuminuria over 3 years in a placebo-controlled study in type 2 diabetes: results from the Diabetes Atherosclerosis Intervention Study (DAIS).
Topics: Albuminuria; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Body Mass Index; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Progression; Double-Blind Method; Female; Fenofibrate; Fibrinogen; Follow-Up Studies; Glycated Hemoglobin; Homocysteine; Humans; Hyperlipidemias; Hypertension; Hypolipidemic Agents; Incidence; Male; Middle Aged; Models, Biological; Smoking; Treatment Outcome | 2005 |
The beneficial effects of lipid-lowering drugs beyond lipid-lowering effects: a comparative study with pravastatin, atorvastatin, and fenofibrate in patients with type IIa and type IIb hyperlipidemia.
Topics: Adult; Anticholesteremic Agents; Atorvastatin; Cholesterol, LDL; Erythrocyte Deformability; Female; Fenofibrate; Fibrinogen; Heptanoic Acids; Humans; Hyperlipidemias; Hypolipidemic Agents; Male; Middle Aged; Pravastatin; Pyrroles; Triglycerides | 2005 |
The effect of low-dose atorvastatin on circulating monocyte chemoattractant protein-1 in patients with type 2 diabetes complicated by hyperlipidemia.
Topics: Adult; Aged; Atorvastatin; C-Reactive Protein; Chemokine CCL2; Diabetes Mellitus, Type 2; Female; Fibrinogen; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Inflammation; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Pyrroles | 2005 |
[Changes in serum lipids, plasma fibrinogen and other haemostatic parameters induced by ciprofibrate action in hyperlipidemic patients with and without coronary artery disease].
Topics: Adolescent; Adult; Aged; Cholesterol; Clofibric Acid; Coronary Artery Disease; Female; Fibric Acids; Fibrinogen; Hemostasis; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipoproteins; Male; Middle Aged; Pilot Projects; Prospective Studies; Triglycerides | 2006 |
[Randomized FARVATER Study. Part 1. Effect of 10 and 20 mg/day atorvastatin on levels of lipids, C-reactive protein, and fibrinogen in patients with ischemic heart disease and hyperlipidemia].
Topics: Adult; Aged; Anticholesteremic Agents; Atorvastatin; C-Reactive Protein; Dose-Response Relationship, Drug; Female; Fibrinogen; Heptanoic Acids; Humans; Hyperlipidemias; Male; Mass Screening; Middle Aged; Pyrroles | 2006 |
[Effect of therapy with atorvastatin on parameters of postprandial lipemia and factors of inflammation in patients with ischemic heart disease].
Topics: Adult; Anticholesteremic Agents; Atorvastatin; C-Reactive Protein; Female; Fibrinogen; Heptanoic Acids; Humans; Hyperlipidemias; Inflammation; Lipids; Male; Myocardial Ischemia; Postprandial Period; Pyrroles; Treatment Outcome | 2007 |
Decrease in inflammatory cardiovascular risk markers in hyperlipidemic diabetic patients treated with fenofibrate.
Topics: Atherosclerosis; Biomarkers; Blood Sedimentation; C-Reactive Protein; Cholesterol; Diabetes Mellitus, Type 2; Fenofibrate; Fibrinogen; Humans; Hyperlipidemias; Hypolipidemic Agents; Outpatients; Proinsulin; Risk Factors; Triglycerides | 2007 |
Effect of blood viscosity decrease on exercise ST segment depressions in hyperlipidemia.
Topics: Blood Viscosity; Clinical Trials as Topic; Clofibrate; Dextrans; Exercise Test; Fibrinogen; Humans; Hyperlipidemias; Lipoproteins | 1980 |
Effect of celiprolol and metoprolol on lipids, fibrinogen and airways function in hyperlipidaemic hypertensives: a randomised double-blind long-term parallel group trial.
Topics: Adult; Aged; Blood Pressure; Celiprolol; Double-Blind Method; Female; Fibrinogen; Heart Rate; Humans; Hyperlipidemias; Hypertension; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Male; Metoprolol; Middle Aged; Peak Expiratory Flow Rate; Treatment Outcome | 1995 |
A randomized pilot trial of low-dose combination lipid-lowering therapy following coronary artery bypass grafting.
Topics: Analysis of Variance; Bezafibrate; Colestipol; Coronary Artery Bypass; Double-Blind Method; Drug Therapy, Combination; Factor VII; Factor VIII; Female; Fibrinogen; Fibrinolysis; Humans; Hyperlipidemias; Hypolipidemic Agents; Lovastatin; Male; Middle Aged; Pilot Projects; Simvastatin | 1994 |
Ciprofibrate versus gemfibrozil in the treatment of primary hyperlipidaemia.
Topics: Adult; Aged; Clofibric Acid; Double-Blind Method; Female; Fibric Acids; Fibrinogen; Follow-Up Studies; Gemfibrozil; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipoproteins; Male; Middle Aged; Retrospective Studies | 1996 |
Gemfibrozil reduces thrombin generation in patients with combined hyperlipidaemia, without influencing plasma fibrinogen, fibrin gel structure or coagulation factor VII.
Topics: Adult; Aged; Analysis of Variance; Cross-Over Studies; Double-Blind Method; Factor VII; Factor VIIa; Factor XIIa; Fibrin; Fibrinogen; Gels; Gemfibrozil; Humans; Hyperlipidemias; Hypolipidemic Agents; Male; Middle Aged; Stress, Psychological; Thrombin | 1996 |
Modulation of plasma fibrinogen levels by ciprofibrate and gemfibrozil in primary hyperlipidaemia.
Topics: Adult; Clofibric Acid; Female; Fibric Acids; Fibrinogen; Gemfibrozil; Humans; Hyperlipidemias; Hypolipidemic Agents; Male; Middle Aged | 1997 |
Comparison of bezafibrate and simvastatin in the treatment of dyslipidaemia in patients with NIDDM.
Topics: Aged; Apolipoproteins; Bezafibrate; Creatine Kinase; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Fibrinogen; Glycated Hemoglobin; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipids; Lipoproteins; Lovastatin; Male; Middle Aged; Patient Compliance; Simvastatin | 1997 |
Comparison of bezafibrate versus lovastatin for lowering plasma insulin, fibrinogen, and plasminogen activator inhibitor-1 concentrations in hyperlipemic heart transplant patients.
Topics: Bezafibrate; Cross-Over Studies; Female; Fibrinogen; Heart Transplantation; Humans; Hyperlipidemias; Hypolipidemic Agents; Insulin; Lovastatin; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Prospective Studies | 1997 |
Lecithin has no effect on serum lipoprotein, plasma fibrinogen and macro molecular protein complex levels in hyperlipidaemic men in a double-blind controlled study.
Topics: Adult; Apolipoproteins B; Blood Proteins; Cholesterol; Double-Blind Method; Fibrinogen; Glycine max; Humans; Hyperlipidemias; Lipoprotein(a); Lipoproteins; Macromolecular Substances; Male; Middle Aged; Palmitic Acid; Phosphatidylcholines; Plant Oils; Sunflower Oil; Yogurt | 1998 |
Determinants of fibrinogen in an Italian population suffering from claudication. Lower fibrinogen in the south compared to middle and north of Italy. The ADEP Group.
Topics: Diabetes Mellitus; Double-Blind Method; Fibrinogen; Humans; Hyperlipidemias; Hypertension; Intermittent Claudication; Italy; Phthalic Acids; Platelet Aggregation Inhibitors; Risk Factors; Smoking; Vascular Surgical Procedures | 1998 |
Fibrinolytic potential is significantly increased by oestrogen treatment in postmenopausal women with mild dyslipidaemia.
Topics: Adult; Aged; Cross-Over Studies; Double-Blind Method; Drug Administration Schedule; Estradiol; Estrogen Replacement Therapy; Female; Fibrinogen; Fibrinolysis; Humans; Hyperlipidemias; Middle Aged; Postmenopause; Progestins; Tissue Plasminogen Activator | 1998 |
Effects of lipid-lowering drugs on left ventricular function and exercise tolerance in dyslipidemic coronary patients.
Topics: Blood Pressure; Cholesterol, LDL; Coronary Disease; Double-Blind Method; Dyspepsia; Exercise Test; Female; Fenofibrate; Fibrinogen; Heart Rate; Humans; Hyperlipidemias; Hypolipidemic Agents; Male; Middle Aged; Patient Dropouts; Physical Endurance; Simvastatin; Stroke Volume; Treatment Outcome; Triglycerides; Ventricular Dysfunction, Left; Ventricular Function, Left | 1999 |
Comparison of the efficacy of atorvastatin and micronized fenofibrate in the treatment of mixed hyperlipidemia.
Topics: Adolescent; Adult; Aged; Atorvastatin; Biomarkers; Cholesterol, HDL; Cholesterol, LDL; Female; Fenofibrate; Fibrinogen; Follow-Up Studies; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypolipidemic Agents; Lipoprotein(a); Male; Middle Aged; Pyrroles; Treatment Outcome; Triglycerides | 1999 |
Etofibrate decreases factor VII and fibrinogen levels in patients with polymetabolic syndrome.
Topics: Arteriosclerosis; Clofibric Acid; Diabetes Mellitus, Type 1; Factor VII; Fibrinogen; Humans; Hyperlipidemias; Hypertension; Hypolipidemic Agents; Lipids; Male; Middle Aged; Pilot Projects; Risk Factors; Statistics, Nonparametric | 1999 |
Effect of a modified fibrate (Biniwas Retard) on hemorheological alterations in hyperlipemic patients.
Topics: Adult; Blood Viscosity; Cholesterol, HDL; Cholesterol, LDL; Erythrocyte Deformability; Erythrocyte Membrane; Female; Fibrinogen; Hemorheology; Humans; Hypercholesterolemia; Hyperlipidemias; Hypertriglyceridemia; Hypolipidemic Agents; Longitudinal Studies; Male; Membrane Fluidity; Middle Aged; Nicotinic Acids | 1999 |
Extruded dry beans and serum lipoprotein and plasma haemostatic factors in hyperlipidaemic men.
Topics: Apolipoproteins A; Apolipoproteins B; Blood Coagulation Factors; Blood Viscosity; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cross-Over Studies; Diet; Fabaceae; Fibrinogen; Humans; Hyperlipidemias; Lipoprotein(a); Lipoproteins; Male; Middle Aged; Plants, Medicinal; Plasminogen Activator Inhibitor 1; Triglycerides | 2000 |
Efficacy of combination of atorvastatin and micronised fenofibrate in the treatment of severe mixed hyperlipidemia.
Topics: Adolescent; Adult; Aged; Atorvastatin; Cholesterol; Drug Combinations; Female; Fenofibrate; Fibrinogen; Heptanoic Acids; Humans; Hyperlipidemias; Hypolipidemic Agents; Male; Middle Aged; Pyrroles; Triglycerides | 2000 |
Ciprofibrate versus gemfibrozil in the treatment of mixed hyperlipidemias: an open-label, multicenter study.
Topics: Adolescent; Adult; Aged; Apolipoproteins B; Body Weight; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Clofibric Acid; Diet; Female; Fibric Acids; Fibrinogen; Gemfibrozil; Humans; Hyperlipidemias; Hypolipidemic Agents; Male; Middle Aged; Triglycerides | 2001 |
Ciprofibrate increases plasma concentration of platelet-derived growth factor AB in patients with advanced atherosclerosis and hyperlipidemia independently of its hypolipidemic effects.
Topics: Aged; Arteriosclerosis; Aspirin; Clofibric Acid; Drug Therapy, Combination; Female; Fibric Acids; Fibrinogen; Fibrinolytic Agents; Humans; Hyperlipidemias; Hypolipidemic Agents; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Count; Platelet-Derived Growth Factor | 2001 |
Atorvastatin and micronized fenofibrate alone and in combination in type 2 diabetes with combined hyperlipidemia.
Topics: Adult; Aged; Anticholesteremic Agents; Apolipoproteins; Atorvastatin; Blood Glucose; Cholesterol; Cholesterol, LDL; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Fenofibrate; Fibrinogen; Heptanoic Acids; Humans; Hyperlipidemias; Lipoprotein(a); Lipoproteins, HDL; Male; Middle Aged; Pyrroles; Triglycerides | 2002 |
Effects of clofibrate on glucose tolerance, serum insulin, serum lipoproteins and plasma fibrinogen.
Topics: Blood Glucose; Blood Sedimentation; Body Weight; Cholesterol; Clinical Trials as Topic; Clofibrate; Double-Blind Method; Fibrinogen; Glucose Tolerance Test; Humans; Hyperlipidemias; Insulin; Male; Middle Aged; Placebos; Triglycerides | 1977 |
Gemfibrozil as a lipid lowering compound in hyperlipoproteinaemia. A placebo-controlled cross-over trial.
Topics: Adipose Tissue; Adult; Aged; Body Weight; Clinical Trials as Topic; Female; Fibrinogen; Glucose Tolerance Test; Humans; Hypercholesterolemia; Hyperlipidemias; Hypolipidemic Agents; Insulin; Lipoprotein Lipase; Lipoproteins; Male; Middle Aged; Placebos; Triglycerides; Valerates; Xylenes | 1976 |
[Oral anticoagulants and platelet function in hypolipemic therapy using a new clofibrate analog (BM 15.075) (author's transl)].
Topics: Aged; Blood Coagulation; Blood Platelets; Clofibrate; Drug Synergism; Female; Fibrinogen; Humans; Hyperlipidemias; Male; Middle Aged; Phenprocoumon; Platelet Aggregation | 1977 |
Double-blind multicenter trial on a new medium molecular weight glycosaminoglycan. Current therapeutic effects and perspectives for clinical use.
Topics: Adult; Aged; Blood Viscosity; Cholesterol; Clinical Trials as Topic; Double-Blind Method; Erythrocyte Deformability; Female; Fibrinogen; Glycosaminoglycans; Humans; Hyperlipidemias; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type V; Hypertriglyceridemia; Hypolipidemic Agents; Lipoproteins; Male; Middle Aged; Multicenter Studies as Topic; Triglycerides | 1990 |
Effects of 3-glucosaminoglycan sulfate on hemorheologic parameters in hyperlipidemic peripheral vascular disease (PVD) patients: a preliminary double-blind crossover study.
Topics: Adult; Arteriosclerosis; Blood Viscosity; Double-Blind Method; Female; Fibrinogen; Glycosaminoglycans; Humans; Hyperlipidemias; Lipids; Male; Middle Aged | 1989 |
The use of sulodexide in the treatment of peripheral vasculopathy accompanying metabolic diseases. Controlled study in hyperlipidemic and diabetic subjects.
Topics: Adult; Aged; Antithrombin III; Cholesterol, HDL; Clinical Trials as Topic; Diabetes Complications; Diabetes Mellitus; Double-Blind Method; Female; Fibrinogen; Glycosaminoglycans; Humans; Hyperlipidemias; Male; Middle Aged; Triglycerides; Vascular Diseases | 1986 |
The effect of serial therapeutic plasmapheresis on platelet count, coagulation factors, plasma immunoglobulin, and complement levels.
Topics: Albumins; Antithrombin III; Blood Coagulation Factors; Clinical Trials as Topic; Complement System Proteins; Electrolytes; Fibrinogen; Humans; Hyperlipidemias; Immunoglobulins; Partial Thromboplastin Time; Plasma Exchange; Plasmapheresis; Platelet Count; Prothrombin Time | 1986 |
132 other study(ies) available for fibrinogen and Hyperlipemia
| Article | Year |
|---|---|
Interference of lipemia in samples for routine coagulation testing using a Sysmex CS-5100 coagulometer.
Topics: Blood Coagulation Tests; Centrifugation; Diagnostic Errors; Diagnostic Tests, Routine; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hyperlipidemias; Partial Thromboplastin Time; Prothrombin Time | 2019 |
Vascular, inflammatory and metabolic risk factors in relation to dementia in Parkinson's disease patients with type 2 diabetes mellitus.
Topics: Age Factors; Aged; Biomarkers; Blood Glucose; China; Cholesterol, LDL; Dementia; Diabetes Mellitus, Type 2; Female; Fibrinogen; Homocysteine; Humans; Hyperlipidemias; Inflammation; Male; Middle Aged; Parkinson Disease; Prognosis; Retrospective Studies; Risk Assessment; Risk Factors; Vascular Diseases | 2020 |
Thrombogenicity markers for early diagnosis and prognosis in COVID-19: a change from the current paradigm?
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Black or African American; Cardiovascular Diseases; Comorbidity; COVID-19; COVID-19 Testing; Diabetes Mellitus; Early Diagnosis; Female; Fibrin; Fibrin Clot Lysis Time; Fibrinogen; Hospitalization; Humans; Hyperlipidemias; L-Lactate Dehydrogenase; Male; Middle Aged; Obesity; Organ Dysfunction Scores; Prognosis; Prospective Studies; SARS-CoV-2; Thrombelastography; Thrombophilia; Treatment Outcome; White People | 2021 |
Hyperlipidemia-induced hepassocin in the liver contributes to insulin resistance in skeletal muscle.
Topics: Animals; CCAAT-Enhancer-Binding Protein-beta; Endoplasmic Reticulum Stress; Enzyme Activation; ErbB Receptors; Fibrinogen; Hep G2 Cells; Hepatocytes; Humans; Hyperlipidemias; Inflammation; Insulin; Insulin Resistance; JNK Mitogen-Activated Protein Kinases; Liver; Mice, Inbred C57BL; Models, Biological; Muscle, Skeletal; Neoplasm Proteins; p38 Mitogen-Activated Protein Kinases; Palmitic Acid; Phosphorylation; Recombinant Proteins; Transcriptional Activation | 2018 |
Factors related to the initial stroke severity of posterior circulation ischemic stroke.
Topics: Aged; Blood Glucose; Blood Sedimentation; Brain Damage, Chronic; C-Reactive Protein; Cerebral Angiography; Cerebrovascular Circulation; Comorbidity; Diabetes Mellitus; Diffusion Magnetic Resonance Imaging; Disease Progression; Female; Fibrinogen; Humans; Hyperlipidemias; Hypertension; Infarction, Posterior Cerebral Artery; Intracranial Embolism; Ischemic Attack, Transient; Leukocyte Count; Male; Middle Aged; Registries; Republic of Korea; Risk; Risk Factors; Severity of Illness Index; Smoking; Symptom Assessment; Treatment Outcome | 2013 |
Peripheral arterial disease, gender, and depression in the Heart and Soul Study.
Topics: Aged; Biomarkers; Chi-Square Distribution; Comorbidity; Depression; Diabetes Mellitus; Female; Fibrinogen; Humans; Hyperlipidemias; Hypertension; Logistic Models; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Peripheral Arterial Disease; Prevalence; Prospective Studies; Risk Factors; Sex Factors; Smoking; Time Factors | 2014 |
Platelet Reactivity in Patients With Stroke and Hyperlipidemia, GPIbα Assessment.
Topics: Aged; Aged, 80 and over; Blood Platelets; Brain Ischemia; Female; Fibrinogen; Follow-Up Studies; Gene Expression Regulation; Humans; Hyperlipidemias; Integrin beta3; Male; Middle Aged; Platelet Activation; Platelet Glycoprotein GPIb-IX Complex; Stroke; Thrombin | 2016 |
Correlation of the leucocyte count with traditional and non-traditional components of metabolic syndrome.
Topics: Adult; Aged; Aged, 80 and over; Blood Glucose; Blood Pressure; China; Female; Fibrinogen; Humans; Hyperglycemia; Hyperlipidemias; Hypertension; Leukocyte Count; Lipids; Male; Metabolic Syndrome; Middle Aged; Obesity; Prevalence; Transaminases; Uric Acid | 2016 |
[Effect of atorvastatin treatment on the hemorheologic and hemostatic parameters in chronic cerebrovascular patients].
Topics: Aged; Anticholesteremic Agents; Atorvastatin; Blood Viscosity; Cerebrovascular Disorders; Chronic Disease; Drug Administration Schedule; Endothelium, Vascular; Erythrocyte Aggregation; Erythrocyte Deformability; Female; Fibrinogen; Hematocrit; Hemorheology; Hemostasis; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Pyrroles; Stroke; von Willebrand Factor | 2008 |
[Study on the selective removal of plasma low-density lipoprotein and fibrinogen by degraded guar sulfate].
Topics: Fibrinogen; Galactans; Hyperlipidemias; Lipoproteins, LDL; Mannans; Plant Gums; Sulfates | 2008 |
Erythrocyte aggregability and AB0 blood groups.
Topics: ABO Blood-Group System; Adult; Case-Control Studies; Cholesterol; Erythrocyte Aggregation; Female; Fibrinogen; Humans; Hyperlipidemias; Male; Middle Aged; Triglycerides | 2009 |
Fibrinogen independently predicts the development of ischemic stroke in a Taiwanese population: CVDFACTS study.
Topics: Adult; Aged; Antithrombin III; Biomarkers; Brain Ischemia; Factor VII; Female; Fibrinogen; Humans; Hyperlipidemias; Insurance Claim Review; Male; Middle Aged; Obesity; Predictive Value of Tests; Prospective Studies; Risk Factors; Smoking; Stroke; Taiwan; Young Adult | 2009 |
Plasma fibrinogen level may predict critical coronary artery stenosis in young adults with myocardial infarction.
Topics: Adult; Antithrombin III; Biomarkers; Coronary Angiography; Coronary Stenosis; Diabetes Mellitus; Fibrinogen; Humans; Hyperlipidemias; Hypertension; Male; Myocardial Infarction; Predictive Value of Tests; Protein C; Protein S; Risk Factors; Smoking | 2009 |
[Study on the selective removal of plasma low-density lipoprotein and fibrinogen by degraded carrageenan].
Topics: Carrageenan; Fibrinogen; Humans; Hyperlipidemias; Lipoproteins, LDL | 2010 |
Influence of lipoproteins and fibrinogen on pathogenesis of sudden sensorineural hearing loss.
Topics: Adolescent; Adult; Aged; Audiometry; Case-Control Studies; Cochlea; Croatia; Female; Fibrinogen; Hearing Loss, Sensorineural; Hearing Loss, Sudden; Humans; Hyperlipidemias; Male; Middle Aged; Young Adult | 2011 |
Antithrombin III associated with fibrinogen predicts the risk of cerebral ischemic stroke.
Topics: Adult; Aged; Antithrombin III; Biomarkers; Brain Ischemia; C-Reactive Protein; Costs and Cost Analysis; Diabetes Mellitus; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolytic Agents; Humans; Hyperlipidemias; Male; Middle Aged; Predictive Value of Tests; Risk Factors; Stroke; Thrombin; Tissue Plasminogen Activator | 2011 |
Correlations between abdominal circumference and the breakage resistance of the fibrin clot in patients with diabetes mellitus type 2.
Topics: Aged; Brain Ischemia; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Hyperlipidemias; Male; Middle Aged; Myocardial Infarction; Obesity, Abdominal; Platelet Activation; Thrombophilia; Thrombosis; Time; Waist Circumference | 2010 |
Investigation of the potential effects of metformin on atherothrombotic risk factors in hyperlipidemic rats.
Topics: Animals; Antioxidants; Aorta; Atherosclerosis; Blood Coagulation; Body Weight; Carotid Arteries; Cholesterol, HDL; Cholesterol, LDL; Eating; Female; Fibrinogen; Hyperlipidemias; Lipid Peroxidation; Male; Metformin; Nitrites; Oxidative Stress; Rats; Rats, Sprague-Dawley; Risk Factors; Thrombosis | 2011 |
Metabolic abnormalities and viral replication are associated with biomarkers of vascular dysfunction in HIV-infected children.
Topics: Adolescent; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cell Adhesion Molecules; Chemokine CCL2; Child; Cohort Studies; E-Selectin; Female; Fibrinogen; HIV Infections; HIV-1; Humans; Hyperlipidemias; Interleukin-6; Male; Multivariate Analysis; P-Selectin; Risk Factors; Virus Replication | 2012 |
[Prevalence of obesity and cardiovascular risk in the general population of a health area in Extremadura (Spain): the Hermex study].
Topics: Adult; Aged; Blood Glucose; Body Mass Index; Cardiovascular Diseases; Comorbidity; Cross-Sectional Studies; Female; Fibrinogen; Humans; Hyperglycemia; Hyperlipidemias; Hypertension; Male; Middle Aged; Myocardial Ischemia; Obesity; Overweight; Prevalence; Risk Factors; Sampling Studies; Smoking; Spain; Waist Circumference | 2012 |
Effect of a high-fat challenge on the proteome of human postprandial plasma.
Topics: Adult; Complement C3; Complement C4; Diet, High-Fat; Dietary Fats; Electrophoresis, Gel, Two-Dimensional; Fibrinogen; Humans; Hyperlipidemias; Inflammation; Lectins, C-Type; Male; Middle Aged; Oxidative Stress; Postprandial Period; Proteome | 2013 |
Hormone replacement therapy and its relationship to lipid and glucose metabolism in diabetic and nondiabetic postmenopausal women: results from the Third National Health and Nutrition Examination Survey (NHANES III).
Topics: Adult; Aged; Blood Glucose; Cholesterol; Diabetes Mellitus; Estrogen Replacement Therapy; Female; Fibrinogen; Glucose Tolerance Test; Health Surveys; Human Growth Hormone; Humans; Hyperlipidemias; Insulin; Lipids; Lipoproteins; Postmenopause | 2002 |
[Selected inflammatory markers in patients with acute coronary syndrome].
Topics: Adult; Aged; Angina Pectoris; Biomarkers; C-Reactive Protein; Cytokines; Female; Fibrinogen; Humans; Hyperlipidemias; Immunoglobulin E; Immunoglobulin G; Immunoglobulin M; Immunoglobulins; Inflammation; Interleukin 1 Receptor Antagonist Protein; Interleukin-1; Interleukin-2; Interleukin-6; Male; Middle Aged; Sialoglycoproteins; T-Lymphocytes; Tumor Necrosis Factor-alpha | 2002 |
Patients with subclinical Cushing's syndrome due to adrenal adenoma have increased cardiovascular risk.
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Aged; Arteriosclerosis; Blood Glucose; Blood Pressure; Body Constitution; Body Mass Index; Cardiovascular Diseases; Carotid Arteries; Cholesterol; Cushing Syndrome; Diabetes Mellitus, Type 2; Diastole; Fasting; Female; Fibrinogen; Glucose Intolerance; Humans; Hyperlipidemias; Hypertension; Insulin; Insulin Resistance; Male; Middle Aged; Risk Factors; Systole; Triglycerides; Ultrasonography | 2002 |
Effect of prickly pear (Opuntia robusta) on glucose- and lipid-metabolism in non-diabetics with hyperlipidemia--a pilot study.
Topics: Adult; Apolipoproteins B; Blood Glucose; Body Weight; Cholesterol; Cholesterol, LDL; Data Interpretation, Statistical; Fibrinogen; Glucose; Humans; Hypercholesterolemia; Hyperlipidemias; Insulin; Lipid Metabolism; Male; Middle Aged; Opuntia; Pectins; Phytotherapy; Pilot Projects; Plant Preparations; Time Factors; Triglycerides | 2002 |
[Effects of tamoxifen and estrogen replacement therapy on lipid metabolism and some other cardiovascular risk factors. A prospective study in hysterectomised women].
Topics: Administration, Cutaneous; Antithrombin III; Breast Neoplasms; Cardiovascular Diseases; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Depression; Estradiol; Estrogen Replacement Therapy; Female; Fibrinogen; Follow-Up Studies; Hot Flashes; Humans; Hyperlipidemias; Hysterectomy; Italy; Lipids; Middle Aged; Ovariectomy; Platelet Count; Prospective Studies; Risk Factors; Tamoxifen; Triglycerides | 2003 |
Plasma fibrinogen variability in healthy citizens.
Topics: Adolescent; Adult; Age Factors; Aged; Alcohol Drinking; Body Mass Index; Epidemiologic Factors; Family Health; Fibrinogen; Humans; Hyperlipidemias; Hypertension; Italy; Middle Aged; Reproducibility of Results; Seasons; Sex Factors; Smoking | 2002 |
Adiponectin is markedly increased in patients with nephrotic syndrome and is related to metabolic risk factors.
Topics: Adiponectin; Adult; Aged; Blood Pressure; Chronic Disease; Female; Fibrinogen; Humans; Hyperlipidemias; Intercellular Signaling Peptides and Proteins; Male; Middle Aged; Nephrotic Syndrome; Proteins; Proteinuria; Risk Factors; Serum Albumin | 2003 |
Comparative effects of diet and simvastatin on markers of thrombogenicity in patients with coronary artery disease.
Topics: Anticholesteremic Agents; Antineoplastic Agents; Apolipoproteins; Biomarkers; C-Reactive Protein; Coronary Disease; Female; Fibrinogen; Hemostatics; Humans; Hyperlipidemias; Lipoproteins; Male; Matrix Metalloproteinase 9; Middle Aged; Placebo Effect; Protease Inhibitors; Simvastatin; Thromboplastin; Thrombosis; Tissue Inhibitor of Metalloproteinase-1; Tumor Necrosis Factor-alpha | 2003 |
[Effects of cardiovascular risk factors on hemorheologic parameters in cerebrovascular patients].
Topics: Adult; Aged; Alcoholism; Blood Viscosity; Cardiovascular Diseases; Case-Control Studies; Cerebrovascular Disorders; Diabetes Complications; Erythrocyte Aggregation; Erythrocyte Deformability; Female; Fibrinogen; Hematocrit; Hemorheology; Humans; Hyperlipidemias; Male; Middle Aged; Plasma; Risk Factors; Smoking; Stroke | 2003 |
[Effect of xuezhikang on blood lipids, serum oxidized low density lipoprotein, C-reactive protein and fibrinogen in patients with unstable angina pectoris].
Topics: Adult; Aged; Angina, Unstable; C-Reactive Protein; Cholesterol; Drugs, Chinese Herbal; Female; Fibrinogen; Follow-Up Studies; Humans; Hyperlipidemias; Lipoproteins, LDL; Male; Middle Aged; Oryza; Phytotherapy | 2003 |
Hemostatic risk factors in ischemic stroke.
Topics: Adolescent; Adult; Aged; Blood Coagulation Factors; Brain Ischemia; Case-Control Studies; Female; Fibrinogen; Hemostasis; Humans; Hyperlipidemias; Hypertension; Male; Middle Aged; Odds Ratio; Risk Factors; Smoking; Stroke | 2003 |
Hemorheological disturbances in patients with chronic cerebrovascular diseases.
Topics: Adult; Alcohol Drinking; Blood Viscosity; Brain Ischemia; Cerebrovascular Circulation; Cerebrovascular Disorders; Chronic Disease; Diabetes Mellitus; Erythrocyte Aggregation; Female; Fibrinogen; Hematocrit; Hemorheology; Humans; Hyperlipidemias; Hypertension; Ischemic Attack, Transient; Male; Middle Aged; Myocardial Ischemia; Reference Values; Risk Factors; Smoking | 2004 |
Abnormal glucose tolerance--a common risk factor in patients with acute myocardial infarction in comparison with population-based controls.
Topics: Acute Disease; Blood Glucose; Diabetes Mellitus, Type 2; Female; Fibrinogen; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Hyperlipidemias; Hypertension; Insulin Resistance; Lipids; Male; Myocardial Infarction; Proinsulin; Prospective Studies; Risk Factors; Triglycerides | 2004 |
The sialic acid content of fibrinogen decreases during pregnancy and increases in response to fibrate therapy.
Topics: Bezafibrate; Case-Control Studies; Female; Fibrinogen; Gemfibrozil; Humans; Hyperlipidemias; Hypolipidemic Agents; N-Acetylneuraminic Acid; Pregnancy; Protein Subunits; Spectrometry, Mass, Electrospray Ionization; Thrombin Time | 2005 |
Risk factors for first-ever acute ischemic non-embolic stroke in elderly individuals.
Topics: Acute Disease; Aged; Aged, 80 and over; Brain Ischemia; Case-Control Studies; Cholesterol; Female; Fibrinogen; Greece; Humans; Hyperlipidemias; Incidence; Male; Retrospective Studies; Risk Factors; Smoking; Stroke; Uric Acid | 2005 |
[Cardiovascular risk factors in dialyzed patients].
Topics: Adult; Aged; Aged, 80 and over; Albuminuria; Blood Glucose; Blood Pressure; C-Reactive Protein; Calcium; Cardiovascular Diseases; Female; Fibrinogen; Hemodialysis, Home; Humans; Hyperlipidemias; Hypertrophy, Left Ventricular; Kidney Failure, Chronic; Lipids; Male; Middle Aged; Myocardial Ischemia; Peritoneal Dialysis; Phosphates; Poland; Retrospective Studies; Risk Factors; Time Factors | 2004 |
[Plasminogen activator inhibitor-1 (PAI-1) 4G/5G and angiotensin converting enzyme (ACE) I/D gene polymorphisms and fibrinolytic activity in patients with essential hypertension and dyslipidemia].
Topics: Adult; Analysis of Variance; Case-Control Studies; Female; Fibrinogen; Fibrinolysis; Humans; Hyperlipidemias; Hypertension; Hypertrophy, Left Ventricular; Male; Peptidyl-Dipeptidase A; Plasminogen Activator Inhibitor 1; Poland; Polymerase Chain Reaction; Polymorphism, Genetic; Risk Assessment; Risk Factors; Tissue Plasminogen Activator | 2005 |
Enhancement of the coagulation system in spontaneously hypertensive and hyperlipidemic rats.
Topics: alpha-2-Antiplasmin; Animals; Antithrombin III; Blood Coagulation Factors; Disease Models, Animal; Female; Fibrinogen; Hyperlipidemias; Hypertension; Liver; Peptide Hydrolases; Plasminogen; Prothrombin; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; RNA, Messenger | 2005 |
Anti-thrombic activity of Korean herbal medicine, Dae-Jo-Whan and its herbs.
Topics: Adenosine Diphosphate; Animals; Cholesterol, Dietary; Collagen; Disseminated Intravascular Coagulation; Endotoxins; Fibrin; Fibrinogen; Fibrinolysin; Fibrinolytic Agents; Heparin; Hyperlipidemias; Korea; Male; Plant Extracts; Plasminogen; Platelet Aggregation; Rats; Rats, Wistar; Thrombin | 2005 |
Do platelet apoptosis, activation, aggregation, lipid peroxidation and platelet-leukocyte aggregate formation occur simultaneously in hyperlipidemia?
Topics: Adult; Apoptosis; Blood Platelets; Cell Adhesion; Female; Fibrinogen; Glutathione; Humans; Hyperlipidemias; Leukocytes; Lipid Peroxidation; Male; P-Selectin; Phosphatidylserines; Platelet Aggregation; Platelet Glycoprotein GPIb-IX Complex; Reference Values | 2005 |
[Explosion of cardiovascular risks in family practice].
Topics: Adolescent; Adult; Aged; Animals; Cardiovascular Diseases; Coronary Disease; Cross-Sectional Studies; Diabetes Mellitus; Diet; Erectile Dysfunction; Family Practice; Female; Fibrinogen; Fishes; Germany; Humans; Hyperlipidemias; Hypertension; Male; Meta-Analysis as Topic; Middle Aged; Prospective Studies; Risk Factors; Smoking | 2005 |
Full-mouth tooth extraction lowers systemic inflammatory and thrombotic markers of cardiovascular risk.
Topics: Adult; C-Reactive Protein; Cohort Studies; Diabetes Mellitus; Female; Fibrinogen; Follow-Up Studies; Heart Diseases; Humans; Hyperlipidemias; Hypertension; Inflammation Mediators; Leukocyte Count; Longitudinal Studies; Male; Middle Aged; Periodontitis; Plasminogen Activator Inhibitor 1; Platelet Count; Risk Factors; Smoking; Thrombosis; Tissue Plasminogen Activator; Tooth Extraction | 2006 |
Plasma lipids and blood viscosity in patients with cerebrovascular disease.
Topics: Aged; Blood Viscosity; Brain; Cerebral Infarction; Female; Fibrinogen; Hematocrit; Hemorheology; Humans; Hyperlipidemias; Ischemic Attack, Transient; Lipids; Male; Middle Aged; Statistics as Topic | 2006 |
Development of hyperfibrinogenemia in spontaneously hypertensive and hyperlipidemic rats: a potentially useful animal model as a complication of hypertension and hyperlipidemia.
Topics: Animals; Antithrombin III; Blood Coagulation; Disease Models, Animal; Fibrinogen; Fibrinolysis; Hyperlipidemias; Hypertension; Male; Plasminogen; Prothrombin; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Sprague-Dawley; Thrombophilia | 2007 |
Influence of lipids and obesity on haemorheological parameters in patients with deep vein thrombosis.
Topics: Adult; Blood Viscosity; Body Mass Index; Case-Control Studies; Cholesterol; Erythrocyte Aggregation; Erythrocyte Deformability; Female; Fibrinogen; Hemorheology; Humans; Hyperlipidemias; Male; Middle Aged; Obesity; Odds Ratio; Risk Assessment; Risk Factors; Time Factors; Triglycerides; Venous Thrombosis | 2007 |
Interleukin-6-572C>G polymorphism-association with inflammatory variables in Korean men with coronary artery disease.
Topics: Adult; Asian People; Biomarkers; C-Reactive Protein; Coronary Artery Disease; Fibrinogen; Genetic Predisposition to Disease; Genotype; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Inflammation Mediators; Interleukin-6; Korea; Lipids; Male; Middle Aged; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Reference Values | 2008 |
Dietary lipids and coagulation. In vitro studies of the coagulation mechanism in rats fed a hyperlipemic diet.
Topics: Animals; Blood Coagulation Disorders; Blood Coagulation Tests; Cholesterol; Diet, Atherogenic; Dietary Fats; Fibrinogen; Hyperlipidemias; In Vitro Techniques; Rats | 1967 |
[Hypercoagulation in fishermen with hypertension, hyperlipidemia and coronary heart disease].
Topics: Adolescent; Adult; Aged; Blood Coagulation; Coronary Disease; Female; Fibrinogen; Humans; Hyperlipidemias; Hypertension; Male; Middle Aged; Occupations; Platelet Adhesiveness; Sex Factors | 1984 |
Increased ristocetin-cofactor in acute myocardial infarction: a component of the acute phase reaction.
Topics: Adolescent; Adult; Aged; Arteriosclerosis; Cardiovascular Diseases; Factor VIII; Female; Fibrinogen; Humans; Hyperlipidemias; Male; Middle Aged; Myocardial Infarction; Pregnancy; von Willebrand Factor | 1980 |
Relationship of triglyceride levels to thrombosis in patients with coronary artery disease.
Topics: Adult; Aged; Anticoagulants; Antithrombin III; Blood Coagulation Disorders; Coronary Disease; Female; Fibrinogen; Humans; Hyperlipidemias; Male; Middle Aged; Platelet Aggregation; Prospective Studies; Thromboplastin; Thrombosis; Triglycerides | 1983 |
Increased plasma antithrombin III level in hyperlipidemic subjects.
Topics: Adult; Aged; Antithrombin III; Butyrylcholinesterase; Cholesterol; Female; Fibrinogen; Humans; Hyperlipidemias; Liver Cirrhosis; Male; Middle Aged; Obesity; Triglycerides | 1981 |
Comparative effect of clofibrate, garlic and onion on alimentary hyperlipemia.
Topics: Adult; Arteriosclerosis; Clofibrate; Coronary Disease; Fibrinogen; Garlic; Humans; Hyperlipidemias; Lipids; Male; Plants, Medicinal; Vegetables; Whole Blood Coagulation Time | 1981 |
High molecular weight fibrinogen derivatives in hyperlipidemia.
Topics: Adult; Blood Coagulation; Blood Vessels; Child; Cholesterol; Chromatography, Gel; Electrophoresis; Female; Fibrinogen; Fibrinopeptide A; Fibronectins; Humans; Hyperlipidemias; Lipoproteins; Male; Middle Aged; Molecular Weight; Triglycerides | 1981 |
[Effects of lyophilized royal jelly on experimental hyperlipidemia and thrombosis].
Topics: Animals; Bees; Cholesterol; Cholesterol, HDL; Erythrocyte Deformability; Fatty Acids; Fibrinogen; Hyperlipidemias; Insect Hormones; Male; Rats; Rats, Sprague-Dawley; Thrombosis | 1995 |
[Fibrinogen and factor VII in women with dyslipidemia. The preliminary results of the Bellvitge-Costa de Ponent Study. The Bellvitge Study Group].
Topics: Adult; Aged; Cardiovascular Diseases; Cross-Sectional Studies; Factor VII; Female; Fibrinogen; Humans; Hyperlipidemias; Middle Aged; Prospective Studies; Risk Factors; Spain; Statistics, Nonparametric | 1995 |
Etofibrate therapy and effect of added low-dose cholestyramine in patients with combined hyperlipidaemia.
Topics: Adult; Aged; Apolipoproteins; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Clofibric Acid; Drug Synergism; Drug Therapy, Combination; Female; Fibrinogen; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipoprotein(a); Male; Middle Aged; Practice Guidelines as Topic; Triglycerides | 1994 |
[The significance of insulin resistance and hyperlipidemia in microvascular angina (syndrome X)].
Topics: Adult; Aged; Blood Glucose; Blood Pressure; Cholesterol; Cholesterol, LDL; Female; Fibrinogen; Glucose Tolerance Test; Humans; Hyperlipidemias; Insulin; Insulin Resistance; Male; Microvascular Angina; Middle Aged | 1995 |
Prevalence of peripheral arterial occlusive disease and associated risk factors in a sample of southern Sardinian population.
Topics: Adult; Aged; Arterial Occlusive Diseases; Diabetes Mellitus; Female; Fibrinogen; Humans; Hyperlipidemias; Hypertension; Italy; Male; Middle Aged; Obesity; Peripheral Vascular Diseases; Prevalence; Risk Factors; Smoking; Surveys and Questionnaires | 1994 |
Correlation between plasma fibrinogen and serum lipids in rats with hyperlipidemia induced by cholesterol free-high fructose or high cholesterol diet.
Topics: Animals; Antithrombin III; Blood Coagulation; Body Weight; Cholesterol, Dietary; Fibrinogen; Fibrinolysis; Fructose; Hyperlipidemias; Lipids; Male; Rats; Rats, Wistar | 1994 |
[Fibrinolytic system in patients with myocardial infarction and other coronary disease risk factors].
Topics: Aged; alpha-2-Antiplasmin; Coronary Disease; Diabetes Mellitus, Type 2; Female; Fibrinogen; Fibrinolysis; Humans; Hyperlipidemias; Male; Middle Aged; Myocardial Infarction; Plasminogen; Plasminogen Activator Inhibitor 1; Plasminogen Activators; Risk Factors; Survivors | 1994 |
Inheritance conjointly contributing to fibrinolysis and hyperlipidemia.
Topics: Adult; alpha-2-Antiplasmin; Cardiovascular Diseases; Fasting; Female; Fibrinogen; Fibrinolysis; Humans; Hyperlipidemias; Lipids; Lipoproteins; Male; Middle Aged; Plasminogen; Plasminogen Inactivators; Prospective Studies; Regression Analysis; Tissue Plasminogen Activator | 1993 |
Lipid-lowering diets enriched with monounsaturated or polyunsaturated fatty acids but low in saturated fatty acids have similar effects on serum lipid concentrations in hyperlipidemic patients.
Topics: Adult; Aged; Blood Glucose; Blood Pressure; Body Mass Index; Body Weight; Cholesterol; Dietary Fats, Unsaturated; Fatty Acids, Monounsaturated; Fatty Acids, Unsaturated; Female; Fibrinogen; Humans; Hyperlipidemias; Insulin; Lipids; Male; Middle Aged; Nutrition Assessment | 1994 |
Reverse flux filtration: a new mode of therapy improving the efficacy of heparin-induced extracorporeal LDL precipitation in hyperlipidemic hemodialysis patients.
Topics: Blood Component Removal; Chemical Precipitation; Cholesterol, LDL; Female; Fibrinogen; Filtration; Heparin; Humans; Hyperlipidemias; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis | 1993 |
'Silent' cerebral infarction is associated with hypercoagulability, endothelial cell damage, and high Lp(a) levels in elderly Japanese.
Topics: Adult; Aged; Aged, 80 and over; Blood Coagulation Disorders; Brain Ischemia; Cardiovascular Diseases; Cerebral Infarction; Comorbidity; Dementia, Multi-Infarct; Disease Susceptibility; Endothelium, Vascular; Female; Fibrinogen; Humans; Hyperlipidemias; Hypertension; Japan; Lipids; Lipoprotein(a); Magnetic Resonance Imaging; Male; Middle Aged; Prevalence; Risk Factors; Smoking; Thrombomodulin; von Willebrand Factor | 1996 |
Fibrinogen in the offspring of men with premature coronary artery disease.
Topics: Adolescent; Adult; Age Factors; Child; Coronary Disease; Female; Fibrinogen; Genetic Markers; Humans; Hyperlipidemias; Lipids; Male; Middle Aged; Risk Factors | 1995 |
Associations between carotid atherosclerosis and high factor VIII activity, dyslipidemia, and hypertension.
Topics: Adult; Age Factors; Aged; Antithrombin III; Arteriosclerosis; Blood Pressure; Carotid Artery Diseases; Cholesterol; Factor VII; Factor VIII; Female; Fibrinogen; Humans; Hyperlipidemias; Hypertension; Longitudinal Studies; Male; Middle Aged; Sex Factors; Smoking; Taiwan; Triglycerides; Uric Acid | 1997 |
Effect of bezafibrate on hypercoagulability assessed by fluorogenic prothrombin time in hyperlipidemic patients with non-insulin-dependent diabetes mellitus.
Topics: Aged; Bezafibrate; Blood Coagulation; Body Mass Index; Case-Control Studies; Cholesterol; Diabetes Mellitus, Type 2; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Glycated Hemoglobin; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipids; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Prothrombin Time | 1997 |
Hyperlipidaemia and cardiovascular disease.
Topics: Coronary Disease; Fibrinogen; Humans; Hyperlipidemias; Hypolipidemic Agents; Rehabilitation | 1997 |
Cognitive function, vascular risk factors and education. A cross-sectional study based on a cohort of 70-year-old men.
Topics: Aged; Cardiovascular Diseases; Cognition; Cross-Sectional Studies; Diabetes Complications; Educational Status; Fibrinogen; Humans; Hyperlipidemias; Male; Obesity; Psychometrics; Risk Factors; Smoking | 1997 |
[Hypolipidemic action of soy fiber and its effects on platelet aggregation and coagulation time in rats].
Topics: Animals; Dietary Fiber; Fibrinogen; Glycine max; Hyperlipidemias; Male; Platelet Aggregation; Rats; Rats, Sprague-Dawley; Whole Blood Coagulation Time | 1996 |
Plasma levels of nitrite/nitrate and platelet cGMP levels are decreased in patients with atrial fibrillation.
Topics: Aged; Atrial Fibrillation; beta-Thromboglobulin; Blood Platelets; Blood Proteins; Cerebrovascular Disorders; Comorbidity; Cyclic GMP; Diabetes Mellitus; Echocardiography; Female; Fibrinogen; Hemodynamics; Humans; Hyperlipidemias; Hypertension; Male; Middle Aged; Myocardial Ischemia; Nitrates; Nitric Oxide; Nitrites; Risk Factors; Smoking; Thrombophilia | 1997 |
Role of hemostatic risk factors for restenosis in peripheral arterial occlusive disease after transluminal angioplasty.
Topics: Angioplasty, Balloon; Antithrombin III; Arterial Occlusive Diseases; Biomarkers; Blood Coagulation Tests; C-Reactive Protein; Cardiovascular Diseases; Comorbidity; Creatinine; Diabetes Mellitus; Female; Femoral Artery; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Hyperlipidemias; Lipids; Male; Metabolic Clearance Rate; Peptide Fragments; Peptide Hydrolases; Plasminogen Activator Inhibitor 1; Popliteal Artery; Prospective Studies; Prothrombin; Recurrence; Risk; Risk Factors; Smoking; Thrombin; Thrombophilia; Tissue Plasminogen Activator; Treatment Failure; Ultrasonography, Doppler, Color; von Willebrand Factor | 1997 |
[Prevalence of obesity and its relationship with cardiovascular risk in the general population of Albacete].
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Body Weight; Cardiovascular Diseases; Cross-Over Studies; Data Interpretation, Statistical; Diabetes Complications; Female; Fibrinogen; Humans; Hyperlipidemias; Hypertension; Male; Middle Aged; Obesity; Risk Factors; Sex Factors; Spain | 1998 |
Hyperlipidaemia and cardiovascular disease.
Topics: Coronary Disease; Exercise; Female; Fibrinogen; Humans; Hyperlipidemias; Male; Risk Factors; Smoking Cessation | 1998 |
Associations of fibrinogen, factor VII and PAI-1 with baseline findings among 10,500 male participants in a prospective study of myocardial infarction--the PRIME Study. Prospective Epidemiological Study of Myocardial Infarction.
Topics: Alcohol Drinking; Cardiovascular Diseases; Comorbidity; Factor VII; Fibrinogen; France; Humans; Hyperlipidemias; Male; Middle Aged; Myocardial Infarction; Northern Ireland; Obesity; Plasminogen Activator Inhibitor 1; Prospective Studies; Risk Factors; Smoking; Surveys and Questionnaires | 1998 |
Prothrombotic and lipoprotein variables in patients attending a cardiovascular risk management clinic: response to ciprofibrate or lifestyle advice.
Topics: Body Weight; Cardiovascular Diseases; Clofibric Acid; Female; Fibric Acids; Fibrinogen; Humans; Hyperlipidemias; Hypolipidemic Agents; Life Style; Lipoproteins; Liver Function Tests; Male; Middle Aged; Retrospective Studies; Risk Factors | 1998 |
Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure.
Topics: Absorptiometry, Photon; Aged; Apolipoproteins A; Arteriosclerosis; Autoantibodies; Biomarkers; C-Reactive Protein; Carotid Arteries; Cross-Sectional Studies; Female; Fibrinogen; Humans; Hyperlipidemias; Inflammation; Kidney Failure, Chronic; Lipoprotein(a); Lipoproteins, LDL; Male; Middle Aged; Nutrition Assessment; Oxidative Stress; Prevalence; Protein-Energy Malnutrition; Regression Analysis; Risk Factors; Tumor Necrosis Factor-alpha; Tunica Intima; Ultrasonography; Vitamin E | 1999 |
Effect of hypertension and its treatment on lipid, lipoprotein(a), fibrinogen, and bilirubin levels in patients referred for dyslipidemia.
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Bilirubin; Biomarkers; Blood Glucose; Female; Fibrinogen; Follow-Up Studies; Humans; Hyperlipidemias; Hypertension; Lipids; Lipoprotein(a); Male; Middle Aged; Prevalence; Prognosis; Referral and Consultation; Retrospective Studies; Risk Factors; Serum Albumin; Smoking | 1999 |
Increased cerebral CO(2) reactivity after heparin-mediated extracorporal LDL precipitation (HELP) in patients with coronary heart disease and hyperlipidemia.
Topics: Aged; Anticoagulants; Blood Component Removal; Blood Viscosity; Carbon Dioxide; Cerebral Arteries; Cerebrovascular Circulation; Chemical Precipitation; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Extracorporeal Circulation; Fibrinogen; Heparin; Humans; Hyperlipidemias; Lipoprotein(a); Middle Aged; Prospective Studies; Triglycerides; Ultrasonography, Doppler, Transcranial | 1999 |
Atorvastatin and fibrinogen--a small subgroup shows extreme response.
Topics: Adult; Aged; Atorvastatin; Coronary Artery Disease; Female; Fibrinogen; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Lipids; Male; Middle Aged; Pyrroles; Treatment Outcome | 1999 |
Relationship between thyroid hormones and fibrinogen levels.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Female; Fibrinogen; Humans; Hyperlipidemias; Male; Middle Aged; Regression Analysis; Sex Factors; Smoking; Thyroid Hormones; Thyrotropin; Thyroxine | 1999 |
Relationship between apolipoprotein E polymorphism, postprandial hyperlipemia and hemostatic variables in patients with combined hyperlipemia.
Topics: Adult; Apolipoproteins; Apolipoproteins E; Area Under Curve; Blood Glucose; Cardiovascular Diseases; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Factor VII; Female; Fibrinogen; Genotype; Hemostasis; Humans; Hyperlipidemias; Insulin; Linear Models; Male; Middle Aged; Polymorphism, Genetic; Postprandial Period; Triglycerides | 2000 |
Modifications of whole blood filterability during acute myocardial infarction.
Topics: Acute Disease; Aged; Blood Viscosity; Diabetes Complications; Erythrocyte Deformability; Female; Fibrinogen; Fibrinolytic Agents; Filtration; Humans; Hyperlipidemias; Hypertension; Male; Membranes, Artificial; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Myocardium; Necrosis; Polycarboxylate Cement; Thrombolytic Therapy | 2000 |
Untreated growth hormone deficiency explains premature mortality in patients with hypopituitarism.
Topics: Cardiovascular Diseases; Fibrinogen; Human Growth Hormone; Humans; Hyperlipidemias; Hypertension; Hypopituitarism; Insulin; Insulin Resistance; Obesity; Plasminogen Activator Inhibitor 1; Quality of Life; Recombinant Proteins | 1998 |
Effect of gemfibrozil on peripheral atherosclerosis and platelet activation in a pig model of hyperlipidemia.
Topics: Animals; Antibodies; Aorta, Abdominal; Arteriosclerosis; Blood Platelets; Cholesterol; Disease Models, Animal; Fibrinogen; Fluorescent Antibody Technique; Gemfibrozil; Hyperlipidemias; Hypolipidemic Agents; Placebos; Platelet Activation; Platelet Glycoprotein GPIIb-IIIa Complex; Swine | 2000 |
Smoking, other risk factors and fibrinogen levels. evidence of effect modification.
Topics: Adult; Aged; Cholesterol, HDL; Cholesterol, LDL; Cluster Analysis; Cross-Sectional Studies; Effect Modifier, Epidemiologic; Female; Fibrinogen; Humans; Hyperlipidemias; Male; Middle Aged; Risk Factors; Smoking | 2001 |
Hyperlipidaemia and cardiovascular disease.
Topics: Cardiovascular Diseases; Clinical Trials as Topic; Fibrinogen; Follow-Up Studies; Humans; Hyperlipidemias; Lipoproteins, LDL; Multicenter Studies as Topic; Risk | 2001 |
[The status of coagulation and lipid blood spectrum in patients with peptic ulcer complicated by ischemic heart disease].
Topics: Adult; Aged; Blood Coagulation Disorders; Cholesterol, HDL; Chronic Disease; Fibrinogen; Fibrinolysis; Hemostasis; Humans; Hyperlipidemias; Middle Aged; Myocardial Ischemia; Peptic Ulcer; Triglycerides | 2001 |
The concomitant appearance of aggregated erythrocytes, leukocytes and platelets in the peripheral blood of patients with risk factors for atherothrombosis.
Topics: Aged; Arteriosclerosis; Cell Adhesion; Cell Aggregation; Cholesterol; Cholesterol, LDL; Cohort Studies; Comorbidity; Computer Systems; Diabetes Mellitus; Erythrocyte Aggregation; Female; Fibrinogen; Hemorheology; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypertension; Inflammation; Israel; Leukocyte Count; Leukocytes; Male; Middle Aged; Platelet Aggregation; Risk Factors; Smoking; Thrombophilia; Triglycerides | 2001 |
The effects of the addition of micronised fenofibrate on uric acid metabolism in patients receiving indapamide.
Topics: Adult; Aged; Antihypertensive Agents; Apolipoproteins B; Cholesterol; Cholesterol, LDL; Drug Therapy, Combination; Female; Fenofibrate; Fibrinogen; Humans; Hyperlipidemias; Hypertension; Hypolipidemic Agents; Indapamide; Male; Middle Aged; Triglycerides; Uric Acid | 2002 |
Hyperlipidaemia and venous thromboembolism in patients lacking thrombophilic risk factors.
Topics: Adult; Age Factors; Body Mass Index; Case-Control Studies; Cholesterol; Female; Fibrinogen; Humans; Hyperlipidemias; Male; Middle Aged; Multivariate Analysis; Plasminogen Activator Inhibitor 1; Pulmonary Embolism; Risk Factors; Sex Factors; Triglycerides; Venous Thrombosis | 2002 |
[Whole blood- and plasma viscosity in the presence of coronary risk factors. Investigations concerning the characteristics of blood flow and viscosity-effective plasma components in patients with coronary risk factors and risk factor combinations (author'
Topics: alpha-Macroglobulins; Beta-Globulins; Blood Viscosity; Cholesterol; Coronary Disease; Female; Fibrinogen; Humans; Hyperlipidemias; Hypertension; Immunoglobulin G; Immunoglobulin M; Lipoproteins, LDL; Male; Obesity; Smoking; Triglycerides | 1977 |
Treatment of severe diabetic hypertriglyceridaemia by plasma exchange.
Topics: Adult; Blood Viscosity; Cholesterol; Diabetes Mellitus; Female; Fibrinogen; Humans; Hyperlipidemias; Plasmapheresis; Triglycerides | 1978 |
Experimental and clinical evaluation of two "Atromid-S" analogues in relation to their differential modes of action.
Topics: Animals; Body Weight; Butyrates; Clofenapate; Clofibrate; Diabetes Mellitus; Fatty Acids, Nonesterified; Fibrinogen; Humans; Hyperlipidemias; Kinetics; Liver; Male; Organ Size; Rats; Receptors, Cell Surface; Serum Albumin; Species Specificity; Structure-Activity Relationship; Thyroxine-Binding Proteins | 1975 |
[Plasma fibrinogen activity in diabetes mellitus, hyperlipoproteinemia and hyperuricemia (author's transl)].
Topics: Adult; Aged; Blood Coagulation; Diabetes Mellitus; Female; Fibrinogen; Humans; Hyperlipidemias; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Middle Aged; Triglycerides; Uric Acid; Vascular Diseases | 1976 |
Intravascular coagulation in hyperlipidemia.
Topics: Antithrombins; Blood Coagulation; Cholesterol; Chromatography, Agarose; Chromatography, Gel; Disseminated Intravascular Coagulation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Hyperlipidemias; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Molecular Weight; Triglycerides; Ultracentrifugation | 1976 |
Intensive plasmapheresis as a risk factor for arteriosclerotic cardiovascular disease?
Topics: Arteriosclerosis; Blood Viscosity; Erythrocyte Aggregation; Fibrinogen; Humans; Hyperlipidemias; Hypoproteinemia; Lipoproteins, LDL; Lipoproteins, VLDL; Myocardial Infarction; Nephrotic Syndrome; Plasmapheresis; Risk | 1977 |
[Blood viscosity in ischemic heart disease with different types of hyperlipoproteinemia].
Topics: Adult; Aged; Blood Viscosity; Coronary Disease; Female; Fibrinogen; Hematocrit; Humans; Hypercholesterolemia; Hyperlipidemias; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Middle Aged; Triglycerides | 1977 |
Normal levels of fibrinopeptide A in patients with primary hyperlipidemia.
Topics: Cholesterol; Factor VII; Factor X; Fibrinogen; Fibrinopeptide A; Humans; Hyperlipidemias; Prothrombin; Thrombophlebitis; Triglycerides | 1979 |
[Determination of the sterol content in fibrinogen as a method of diagnosing the progression of arteriosclerosis].
Topics: Adult; Coronary Disease; Fibrinogen; Humans; Hyperlipidemias; Male; Middle Aged; Sterols | 1978 |
Assay of fibrinopeptides A and B and of released platelet proteins as a measure of activation of hemostasis.
Topics: Blood Coagulation Tests; Blood Platelets; Fibrinogen; Humans; Hyperlipidemias; Radioimmunoassay | 1978 |
The relationship of coagulation factors to clinical complications of acute pancreatitis.
Topics: Acute Disease; Adult; Aged; Alcoholism; Aspartate Aminotransferases; Biliary Tract Diseases; Blood Coagulation Factors; Blood Platelets; Female; Fibrinogen; Humans; Hyperlipidemias; Hypertension, Pulmonary; Hypoxia; Kidney Diseases; L-Lactate Dehydrogenase; Liver; Lung; Male; Middle Aged; Pancreatitis; Pulmonary Embolism | 1977 |
[Circulation time of 125I-labeled fibrinogen in patients with ischemic heart disease with different types of hyperlipoproteinemia].
Topics: Adult; Aged; Blood Coagulation; Coronary Disease; Female; Fibrinogen; Half-Life; Humans; Hyperlipidemias; Iodine Radioisotopes; Isotope Labeling; Male; Middle Aged; Time Factors | 1976 |
Changes in the hemostatic system and compensatory responses during alimentary hyperlipidemia.
Topics: Adenosine Diphosphate; Animals; Blood Coagulation; Blood Platelets; Cholesterol; Fibrinogen; Fluorescence Polarization; Hyperlipidemias; Male; Membrane Fluidity; Membrane Lipids; Phospholipids; Platelet Aggregation; Rats; Rats, Inbred Strains; Thrombin; Triglycerides | 1991 |
Lipid, lipoprotein, and hemostatic effects of fish vs fish-oil n-3 fatty acids in mildly hyperlipidemic males.
Topics: Adult; Animals; Bleeding Time; Blood Pressure; Cholesterol; Docosahexaenoic Acids; Eicosapentaenoic Acid; Fatty Acids; Fibrinogen; Fish Oils; Fishes; Hemostasis; Humans; Hyperlipidemias; Lipids; Lipoproteins; Male; Middle Aged; Thromboxanes; Triglycerides | 1991 |
[Rheologic changes in the postprandial phase].
Topics: Adult; Blood Viscosity; Cholesterol; Coronary Disease; Dietary Fats; Erythrocyte Aggregation; Fibrinogen; Humans; Hyperlipidemias; Lipids; Retrospective Studies; Risk Factors; Triglycerides | 1990 |
Comparison of an immunochemical assay for plasma fibrinogen and a turbidimetric thrombin clotting technique to discriminate hyperlipidaemic patients from healthy controls.
Topics: Adult; Aged; Fibrinogen; Humans; Hyperlipidemias; Immunodiffusion; Middle Aged; Nephelometry and Turbidimetry; Risk Factors; Thrombin Time | 1990 |
CHD risk factors: a Framingham study update.
Topics: Aged; Cardiomegaly; Cohort Studies; Coronary Disease; Female; Fibrinogen; Humans; Hyperlipidemias; Hypertension; Lipids; Longitudinal Studies; Male; Middle Aged; Multivariate Analysis; Risk Factors | 1990 |
Changes in coagulative and fibrinolytic activities in Triton WR-1339-induced hyperlipidemia in rats.
Topics: alpha-2-Antiplasmin; Animals; Antithrombin III; Blood Cell Count; Blood Coagulation; Cholesterol; Factor XIII; Fibrinogen; Fibrinolysis; Hyperlipidemias; Lipids; Male; Partial Thromboplastin Time; Plasminogen; Polyethylene Glycols; Prothrombin Time; Rats; Rats, Inbred Strains | 1990 |
[Characteristics of hemostasis, fibrinolysis and lipid indicators in children and their fathers with a history of myocardial infarction at a young age].
Topics: Adolescent; Adult; Antithrombin III Deficiency; Blood Coagulation; Child; Cholesterol; Cholesterol, HDL; Coronary Disease; Disease Susceptibility; Female; Fibrinogen; Fibrinolysin; Fibrinolysis; Humans; Hyperlipidemias; Male; Middle Aged; Myocardial Infarction; Plasminogen Activators; Triglycerides | 1986 |
[Hemostatic changes during pregnancy in reference to hyperlipidemia].
Topics: Blood Coagulation; Female; Fibrinogen; Fibrinolysis; Humans; Hyperlipidemias; Lipids; Platelet Aggregation; Pregnancy; Pregnancy Complications | 1988 |
Hypertension and other risk factors in coronary heart disease.
Topics: Adult; Aged; Aged, 80 and over; Coronary Disease; Electrocardiography; Female; Fibrinogen; Humans; Hyperglycemia; Hyperlipidemias; Hypertension; Lipoproteins; Male; Middle Aged; Risk Factors; Smoking | 1987 |
[The significance of arterial hypertonia and cerebral vessel wall changes within the scope of hemorheologic changes in ischemic insult].
Topics: Adult; Aged; Aged, 80 and over; Brain Ischemia; Cerebral Angiography; Cerebral Arteries; Cerebral Veins; Diabetes Complications; Erythrocyte Aggregation; Erythrocyte Deformability; Female; Fibrinogen; Hematocrit; Humans; Hyperlipidemias; Hypertension; Male; Middle Aged; Rheology; Risk | 1986 |
Letter: Essential oil of garlic in prevention of atherosclerosis.
Topics: Arteriosclerosis; Blood Coagulation; Blood Coagulation Tests; Cholesterol; Diet; Dietary Fats; Fibrinogen; Fibrinolysis; Garlic; Humans; Hyperlipidemias; Oils, Volatile; Plant Extracts; Plants, Medicinal; Vegetables | 1973 |
Impaired fibrinolytic response to exercise in patients with type-IV hyperlipoproteinaemia.
Topics: Adult; Arteriosclerosis; Cholesterol; Coronary Disease; Fibrinogen; Fibrinolysis; Heart Rate; Humans; Hyperlipidemias; Male; Middle Aged; Oxygen Consumption; Physical Exertion; Plasminogen; Triglycerides | 1970 |
Resting levels of blood fibrinolysis in hyperlipoproteinemia.
Topics: Adolescent; Adult; Cholesterol; Enzyme Activation; Female; Fibrinogen; Fibrinolysin; Fibrinolysis; Humans; Hyperlipidemias; Male; Middle Aged; Plasminogen; Serum Globulins; Triglycerides | 1974 |
[Apropos of a case of surgical chyluria. Factors of decompensation. Surgical indications].
Topics: Albuminuria; Chyle; Chylomicrons; Fibrinogen; Filariasis; Ganglia; Glucose Tolerance Test; Glycosuria; Hematuria; Humans; Hyperlipidemias; Lymphatic System; Lymphocytes; Lymphography; Male; Middle Aged; Polyuria; Radiography, Thoracic; Thoracic Duct; Tomography; Tuberculosis, Pulmonary; Urine; Urography; Vomiting | 1969 |
[Hyperlipemia in flying personnel (civil aviation)].
Topics: Aerospace Medicine; Belgium; Cholesterol; Clofibrate; Fibrinogen; Humans; Hyperlipidemias; Phospholipids; Triglycerides | 1972 |
Impairment of the diurnal fibrinolytic response in man. Effects of aging, type IV hyperlipoproteinemia, and coronary artery disease.
Topics: Adult; Aging; Circadian Rhythm; Coronary Disease; Factor Analysis, Statistical; Female; Fibrinogen; Fibrinolysis; Humans; Hyperlipidemias; Lipoproteins; Male; Middle Aged; Plasminogen; Triglycerides | 1973 |
Erythrocyte sedimentation rate in hyperlipidaemia.
Topics: Blood Sedimentation; Fibrin; Fibrinogen; Humans; Hyperlipidemias; Platelet Adhesiveness | 1973 |
Clotting mechanisms in patients with hypertriglyceridemia during therapy with anabolic or progestational drugs.
Topics: Adenosine Diphosphate; Blood Coagulation; Cholesterol; Electrophoresis, Paper; Factor IX; Factor V; Factor VII; Factor VIII; Factor X; Female; Fibrinogen; Follow-Up Studies; Humans; Hyperlipidemias; Male; Norethindrone; Oxandrolone; Prothrombin; Prothrombin Time; Thrombin; Triglycerides | 1973 |
[Physiopathology of the process of fibrin stabilization].
Topics: Abortion, Septic; Anuria; Arteriosclerosis; Blood Coagulation Disorders; Disseminated Intravascular Coagulation; Factor XIII; Female; Fibrinogen; Fibrinolysis; Humans; Hyperlipidemias; Leukemia; Liver Cirrhosis; Pregnancy | 1973 |
[Effect of short-term treatment with chlorophenoxyisobutyrate on serum lipids and pseudocholinesterase and plasmatic fibrinogen in hyperlipemic patients].
Topics: Adult; Butyrylcholinesterase; Cholinesterases; Clofibrate; Female; Fibrinogen; Humans; Hyperlipidemias; Lipids; Male; Middle Aged | 1973 |
[Essential hyperlipemia and decreased fibrinolysis activity].
Topics: Antifibrinolytic Agents; Fatty Acids; Fibrinogen; Fibrinolysis; Humans; Hyperlipidemias; Phospholipids; Plasminogen; Triglycerides | 1967 |
[Studies on decrease of serum lipids and acceleration of fibrinolysis induced by phosphatidyl choline].
Topics: Blood Coagulation; Blood Coagulation Tests; Cholesterol; Depression, Chemical; Fibrinogen; Fibrinolysis; Humans; Hyperlipidemias; In Vitro Techniques; Lipids; Lipoproteins; Phosphatidylcholines; Phospholipids; Stimulation, Chemical | 1971 |
[Studies on the adhesiveness of human blood platelets--the pathophysiological significance of the adhesiveness of the human blood platelets in alimentary lipemia in coronary sclerosis].
Topics: Adhesiveness; Adult; Aged; Arteriosclerosis; Blood Platelets; Calcium; Coronary Disease; Dextrans; Dietary Fats; Female; Fibrinogen; Humans; Hyperlipidemias; In Vitro Techniques; Male; Middle Aged | 1969 |
[Arterial ischemic syndrome associated with plasma cryoprecipitation and cutaneous porphyria in adults].
Topics: Adenine Nucleotides; Adult; Antigen-Antibody Reactions; Autoantibodies; Blood Proteins; Chemical Precipitation; Cold Temperature; Fibrinogen; Fibrinolytic Agents; Humans; Hyperlipidemias; Immunoglobulin G; Immunoglobulins; Ischemia; Male; Porphyrias; Raynaud Disease; Skin Diseases | 1970 |
[Effect of seasonal factors on blood lipid levels and some blood coagulation indices in patients with arteriosclerosis and essential hyperlipidemia].
Topics: Arteriosclerosis; Blood Coagulation; Cholesterol; Female; Fibrinogen; Fibrinolysis; Heparin; Humans; Hyperlipidemias; Lipids; Lipoproteins; Male; Methods; Phospholipids; Prothrombin; Seasons; Time Factors | 1970 |
[Action mechanism and clinical success of Regelan (Clofibrate)].
Topics: Androsterone; Anticholesteremic Agents; Butyrates; Cholesterol; Diabetic Retinopathy; Fibrinogen; Humans; Hypercholesterolemia; Hyperlipidemias; Triglycerides | 1967 |
Failure of safflower oil hyperlipemia to inhibit limitation of the size of experimental streptokinase-treated myocardial infarction.
Topics: Animals; Blood Coagulation Tests; Coronary Disease; Dogs; Fatty Acids, Essential; Fibrinogen; Fibrinolysis; Hyperlipidemias; Myocardial Infarction; Myocardium; Prothrombin Time; Streptokinase; Thrombelastography | 1968 |
[Studies on the relationship between serum cholesterol and plasma fibrinogen].
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Cholesterol; Diabetes Mellitus; Dwarfism, Pituitary; Fatty Liver; Female; Fibrinogen; Humans; Hyperlipidemias; Male; Middle Aged; Nephrotic Syndrome; Obesity | 1968 |